Publications

  1. Vijayvargiya P, Camilleri M. Proximal megacolon in an adult. Clin Gastroenterol Hepatol. 2014 Sep; 12(9):e83-4. Epub 2013 Jun 28.
    View PubMed
  2. Camilleri M. Novel therapeutic agents in neurogastroenterology: advances in the past year. Neurogastroenterol Motil. 2014 Aug; 26(8):1070-8. Epub 2014 Jun 23.
    View PubMed
  3. Camilleri M, Busciglio I, Acosta A, Shin A, Carlson P, Burton D, Ryks M, Rhoten D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Effect of Increased Bile Acid Synthesis or Fecal Excretion in Irritable Bowel Syndrome-Diarrhea. Am J Gastroenterol. 2014 Jul 29.
    View PubMed
  4. Bharucha AE, Kudva Y, Basu A, Camilleri M, Low PA, Vella A, Zinsmeister AR. Relationship Between Glycemic Control and Gastric Emptying in Poorly Controlled Type 2 Diabetes. Clin Gastroenterol Hepatol. 2014 Jul 17.
    View PubMed
  5. Camilleri M. Intestinal Secretory Mechanisms in Irritable Bowel Syndrome-Diarrhea. Clin Gastroenterol Hepatol. 2014 Jul 17.
    View PubMed
  6. Camilleri M. Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms. J Physiol. 2014 Jul 15; 592(Pt 14):2967-80. Epub 2014 Mar 24.
    View PubMed
  7. Camilleri M, Shin A, Busciglio IA, Carlson P, Acosta A, Bharucha AE, Burton DD, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Genetic Variation in GPBAR1 Predisposes to Quantitative Changes in Colonic Transit and Bile Acid Excretion. Am J Physiol Gastrointest Liver Physiol. 2014 Jul 10.
    View PubMed
  8. Katzka DA, Geno DM, Ravi A, Smyrk TC, Lao-Sirieix P, Miramedi A, Debiram I, O'Donovan M, Kita H, Kephart GM, Kryzer LA, Camilleri M, Alexander JA, Fitzgerald RC. Accuracy, Safety, and Tolerability of Tissue Collection by Cytosponge vs Endoscopy for Evaluation of Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2014 Jul 03.
    View PubMed
  9. Acosta A, Camilleri M. Elobixibat and its potential role in chronic idiopathic constipation. Therap Adv Gastroenterol. 2014 Jul; 7(4):167-75.
    View PubMed
  10. Katzka DA, Geno DM, Blair HE, Lamsam JL, Alexander JA, Camilleri M. Small intestinal permeability in patients with eosinophilic oesophagitis during active phase and remission. Gut. 2014 Jun 23.
    View PubMed
  11. Camilleri M, Carlson P, Acosta A, Busciglio I, Nair AA, Gibbons SJ, Farrugia G, Klee EW. RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study. Am J Physiol Gastrointest Liver Physiol. 2014 Jun 15; 306(12):G1089-98. Epub 2014 Apr 24.
    View PubMed
  12. Beyder A, Mazzone A, Strege PR, Tester DJ, Saito YA, Bernard CE, Enders FT, Ek WE, Schmidt PT, Dlugosz A, Lindberg G, Karling P, Ohlsson B, Gazouli M, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Camilleri M, Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. Gastroenterology. 2014 Jun; 146(7):1659-68. Epub 2014 Mar 05.
    View PubMed
  13. Bharucha AE, Fletcher JG, Camilleri M, Edge J, Carlson P, Zinsmeister AR. Effects of clonidine in women with fecal incontinence. Clin Gastroenterol Hepatol. 2014 May; 12(5):843-851.e2; quiz e44. Epub 2013 Jul 23.
    View PubMed
  14. Acosta A, Abu Dayyeh BK, Port JD, Camilleri M. Recent advances in clinical practice challenges and opportunities in the management of obesity. Gut. 2014 Apr; 63(4):687-95. Epub 2014 Jan 08.
    View PubMed
  15. Acosta A, Camilleri M. Gastrointestinal morbidity in obesity. Ann N Y Acad Sci. 2014 Apr; 1311:42-56. Epub 2014 Mar 06.
    View PubMed
  16. Katzka DA, Tadi R, Smyrk TC, Katarya E, Sharma A, Geno DM, Camilleri M, Iyer PG, Alexander JA, Buttar NS. Effects of Topical Steroids on Tight Junction Proteins and Spongiosis in Esophageal Epithelia of Patients With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2014 Mar 27.
    View PubMed
  17. Acosta A, Camilleri M, Shin A, Carlson P, Burton D, O'Neill J, Eckert D, Zinsmeister AR. Association of melanocortin 4 receptor gene variation with satiation and gastric emptying in overweight and obese adults. Genes Nutr. 2014 Mar; 9(2):384. Epub 2014 Jan 24.
    View PubMed
  18. Vijayvargiya P, Iturrino J, Camilleri M, Shin A, Vazquez-Roque M, Katzka DA, Snuggerud JR, Seime RJ. Novel Association of Rectal Evacuation Disorder and Rumination Syndrome: Diagnosis, Co-morbidities and Treatment. United European Gastroenterol J. 2014 Feb 1; 2(1):38-46.
    View PubMed
  19. Shin A, Camilleri M, Kolar G, Erwin P, West CP, Murad MH. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation. Aliment Pharmacol Ther. 2014 Feb; 39(3):239-53. Epub 2013 Dec 5
    View PubMed
  20. Grover M, Camilleri M, Smith K, Linden DR, Farrugia G. On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens. Neurogastroenterol Motil. 2014 Feb; 26(2):156-67.
    View PubMed
  21. Shah M, Law JH, Micheletto F, Sathananthan M, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Zinsmeister AR, Vella A. Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes. 2014 Feb; 63(2):483-93. Epub 2013 Oct 02.
    View PubMed
  22. Iturrino J, Camilleri M, Busciglio I, Burton D, Zinsmeister AR. Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome. Dig Liver Dis. 2014 Feb; 46(2):113-8. Epub 2013 Oct 04.
    View PubMed
  23. Camilleri M, Klee EW, Shin A, Carlson P, Li Y, Grover M, Zinsmeister AR. Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit. Am J Physiol Gastrointest Liver Physiol. 2014 Jan 1; 306(1):G13-26. Epub 2013 Nov 07.
    View PubMed
  24. Kolar GJ, Camilleri M, Burton D, Nadeau A, Zinsmeister AR. Prevalence of colonic motor or evacuation disorders in patients presenting with chronic nausea and vomiting evaluated by a single gastroenterologist in a tertiary referral practice. Neurogastroenterol Motil. 2014 Jan; 26(1):131-8. Epub 2013 Oct 10.
    View PubMed
  25. Camilleri M. Advances in understanding of bile acid diarrhea. Expert Rev Gastroenterol Hepatol. 2014 Jan; 8(1):49-61. Epub 2013 Nov 25
    View PubMed
  26. Grover M, Camilleri M, Smith K, Linden DR, Farrugia G. Postinfectious irritable bowel syndrome: Mechanisms related to pathogens. Neurogastroenterol Motil. 2014; 26(2):156-67.
  27. Camilleri M, Klee EW, Shin A, Carlson P, Li Y, Grover M, Zinsmeister AR. Irritable bowel syndrome-diarrhea: Characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit. American Journal of Physiology - Gastrointestinal and Liver Physiology. 2014; 306(1):G13-26.
  28. Sathananthan M, Ikramuddin S, Swain JM, Shah M, Piccinini F, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Vella A. The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects. Diabetes Metab Syndr Obes. 2014; 7:305-12. Epub 2014 Jul 11.
    View PubMed
  29. Shin A, Camilleri M, Busciglio I, Burton D, Smith SA, Vella A, Ryks M, Rhoten D, Zinsmeister AR. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus. Clin Gastroenterol Hepatol. 2013 Nov; 11(11):1453-1459.e4. Epub 2013 Apr 30.
    View PubMed
  30. Maurer AH, Camilleri M, Donohoe K, Knight LC, Madsen JL, Mariani G, Parkman HP, Van Dolsen J. The SNMMI and EANM practice guideline for small-bowel and colon transit 1.0. J Nucl Med. 2013 Nov; 54(11):2004-13. Epub 2013 Oct 03.
    View PubMed
  31. Camilleri M. Pharmacological agents currently in clinical trials for disorders in neurogastroenterology. J Clin Invest. 2013 Oct 01; 123(10):4111-20.
    View PubMed
  32. Shin A, Camilleri M, Vijayvargiya P, Busciglio I, Burton D, Ryks M, Rhoten D, Lueke A, Saenger A, Girtman A, Zinsmeister AR. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013 Oct; 11(10):1270-1275.e1. Epub 2013 Apr 30.
    View PubMed
  33. Shin AS, Camilleri M. Diagnostic assessment of diabetic gastroparesis. Diabetes. 2013 Aug; 62(8):2667-73.
    View PubMed
  34. Vijayvargiya P, Camilleri M, Shin A, Breen M, Burton D. Simplifying the measurement of gastric accommodation using SPECT. Neurogastroenterol Motil. 2013 Jun; 25(6):542-6. Epub 2013 Feb 17.
    View PubMed
  35. Shin A, Camilleri M, Nadeau A, Nullens S, Rhee JC, Jeong ID, Burton DD. Interpretation of overall colonic transit in defecation disorders in males and females. Neurogastroenterol Motil. 2013 Jun; 25(6):502-8. Epub 2013 Feb 14.
    View PubMed
  36. Camilleri M. Genetics of human gastrointestinal sensation. Neurogastroenterol Motil. 2013 Jun; 25(6):458-66. Epub 2013 Apr 17.
    View PubMed
  37. Camilleri M. Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome. Expert Opin Pharmacother. 2013 Jun; 14(9):1151-60. Epub 2013 Apr 27.
    View PubMed
  38. Bharucha AE, Low P, Camilleri M, Veil E, Burton D, Kudva Y, Shah P, Gehrking T, Zinsmeister AR. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013 May; 62(5):708-15. Epub 2012 Jun 07.
    View PubMed
  39. Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, Marietta E, O'Neill J, Carlson P, Lamsam J, Janzow D, Eckert D, Burton D, Zinsmeister AR. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013 May; 144(5):903-911.e3. Epub 2013 Jan 25.
    View PubMed
  40. Iturrino J, Camilleri M, Wong BS, Linker Nord SJ, Burton D, Zinsmeister AR. Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation. Aliment Pharmacol Ther. 2013 Apr; 37(8):776-85. Epub 2013 Mar 04.
    View PubMed
  41. Schemann M, Camilleri M. Functions and imaging of mast cell and neural axis of the gut. Gastroenterology. 2013 Apr; 144(4):698-704.e4. Epub 2013 Jan 24.
    View PubMed
  42. Camilleri M, Kolar GJ, Vazquez-Roque MI, Carlson P, Burton DD, Zinsmeister AR. Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits. Am J Physiol Gastrointest Liver Physiol. 2013 Mar 1; 304(5):G553-60. Epub 2013 Jan 10.
    View PubMed
  43. Camilleri M, Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013 Mar; 10(3):187-94. Epub 2013 Feb 05.
    View PubMed
  44. Zinsmeister AR, Burton D, Camilleri M. Pharmacodynamic and clinical endpoints for functional colonic disorders: statistical considerations. Dig Dis Sci. 2013 Feb; 58(2):509-18. Epub 2012 Aug 24.
    View PubMed
  45. Grover M, Camilleri M. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases. J Gastroenterol. 2013 Feb; 48(2):177-81. Epub 2012 Dec 20.
    View PubMed
  46. Wong BS, Camilleri M. Elobixibat for the treatment of constipation. Expert Opin Investig Drugs. 2013 Feb; 22(2):277-84. Epub 2012 Dec 08.
    View PubMed
  47. Topazian M, Camilleri M, Enders FT, Clain JE, Gleeson FC, Levy MJ, Rajan E, Nehra V, Dierkhising RA, Collazo-Clavell ML, Talley NJ, Clark MM. Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):145-50.e1. Epub 2012 Oct 09.
    View PubMed
  48. Tack J, Quigley E, Camilleri M, Vandeplassche L, Kerstens R. Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis. United European Gastroenterol J. 2013 Feb; 1(1):48-59.
    View PubMed
  49. Shin A, Camilleri M, Busciglio I, Burton D, Stoner E, Noonan P, Gottesdiener K, Smith SA, Vella A, Zinsmeister AR. Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics. Diabetes Care. 2013 Jan; 36(1):41-8. Epub 2012 Sep 06.
    View PubMed
  50. Bharucha AE, Camilleri M, Veil E, Burton D, Zinsmeister AR. Comprehensive assessment of gastric emptying with a stable isotope breath test. Neurogastroenterol Motil. 2013 Jan; 25(1):e60-9. Epub 2012 Dec 06.
    View PubMed
  51. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L, American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013 Jan; 108(1):18-37; quiz 38. Epub 2012 Nov 13.
    View PubMed
  52. Grover M, Camilleri M. Treatment with Methylnaltrexone and IVIG for Paraneoplastic Gastrointestinal Dysmotility. Gastroenterol Hepatol (N Y). 2013 Jan; 9(1):51-3.
    View PubMed
  53. Raffals L, Camilleri M. Visceral hypersensitivity and IBD. Inflammatory Bowel Disease Monitor. 2013; 13(3):85-91.
  54. Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, O'Neill J, Carlson P, Lamsam J, Eckert D, Janzow D, Burton D, Ryks M, Rhoten D, Zinsmeister AR. Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol. 2012 Dec 1; 303(11):G1262-9. Epub 2012 Oct 04.
    View PubMed
  55. Camilleri M, Iturrino J, Bharucha AE, Burton D, Shin A, Jeong ID, Zinsmeister AR. Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants. Neurogastroenterol Motil. 2012 Dec; 24(12):1076-e562. Epub 2012 Jul 02.
    View PubMed
  56. Zinsmeister AR, Bharucha AE, Camilleri M. Comparison of calculations to estimate gastric emptying half-time of solids in humans. Neurogastroenterol Motil. 2012 Dec; 24(12):1142-5. Epub 2012 Jul 20.
    View PubMed
  57. Camilleri M. Irritable bowel syndrome: how useful is the term and the 'diagnosis'? Therap Adv Gastroenterol. 2012 Nov; 5(6):381-6.
    View PubMed
  58. Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 2012 Oct 25; 367(17):1626-35.
    View PubMed
  59. Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 Oct; 303(7):G775-85. Epub 2012 Jul 26.
    View PubMed
  60. Katzka DA, Loftus EV Jr, Camilleri M. Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseases. Clin Pharmacol Ther. 2012 Sep; 92(3):306-20. Epub 2012 Jul 25.
    View PubMed
  61. Wong BS, Camilleri M, Carlson P, McKinzie S, Busciglio I, Bondar O, Dyer RB, Lamsam J, Zinsmeister AR. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol. 2012 Sep; 10(9):1009-15.e3. Epub 2012 May 18.
    View PubMed
  62. Nullens S, Nelsen T, Camilleri M, Burton D, Eckert D, Iturrino J, Vazquez-Roque M, Zinsmeister AR. Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation. Gut. 2012 Aug; 61(8):1132-9. Epub 2011 Dec 16.
    View PubMed
  63. Iturrino J, Camilleri M, Busciglio I, Burton D, Zinsmeister AR. Sensations of gas and pain and their relationship with compliance during distension in human colon. Neurogastroenterol Motil. 2012 Jul; 24(7):646-51, e275. Epub 2012 Mar 06.
    View PubMed
  64. Camilleri M, Grover M, Farrugia G. What are the important subsets of gastroparesis? Neurogastroenterol Motil. 2012 Jul; 24(7):597-603. Epub 2012 May 24.
    View PubMed
  65. Camilleri M, Vazquez-Roque M, Iturrino J, Boldingh A, Burton D, McKinzie S, Wong BS, Rao AS, Kenny E, Mansson M, Zinsmeister AR. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 Jul; 303(1):G120-8. Epub 2012 Apr 19.
    View PubMed
  66. Kimpinski K, Iodice V, Burton DD, Camilleri M, Mullan BP, Lipp A, Sandroni P, Gehrking TL, Sletten DM, Ahlskog JE, Fealey RD, Singer W, Low PA. The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy. J Neurol Sci. 2012 Jun 15; 317(1-2):92-6. Epub 2012 Mar 14.
    View PubMed
  67. Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012 Jun; 24(6):503-12.
    View PubMed
  68. Money ME, Camilleri M. Review: Management of postprandial diarrhea syndrome. Am J Med. 2012 Jun; 125(6):538-44.
    View PubMed
  69. Camilleri M, Katzka DA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 May 15; 302(10):G1075-84. Epub 2012 Mar 08.
    View PubMed
  70. Wong BS, Camilleri M, Carlson PJ, Odunsi-Shiyanbade S, McKinzie S, Busciglio I, Burton D, Zinsmeister AR. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea. Dig Dis Sci. 2012 May; 57(5):1222-6. Epub 2012 Jan 21.
    View PubMed
  71. Revicki DA, Camilleri M, Kuo B, Szarka LA, McCormack J, Parkman HP. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD). Neurogastroenterol Motil. 2012 May; 24(5):456-63, e215-6. Epub 2012 Jan 27.
    View PubMed
  72. Wong BS, Camilleri M, Eckert D, Carlson P, Ryks M, Burton D, Zinsmeister AR. Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Neurogastroenterol Motil. 2012 Apr; 24(4):358-e169. Epub 2012 Jan 30.
    View PubMed
  73. Tack J, Camilleri M, Chang L, Chey WD, Galligan JJ, Lacy BE, Muller-Lissner S, Quigley EM, Schuurkes J, De Maeyer JH, Stanghellini V. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012 Apr; 35(7):745-67. Epub 2012 Feb 22.
    View PubMed
  74. Camilleri M, Di Lorenzo C. Brain-gut axis: from basic understanding to treatment of IBS and related disorders. J Pediatr Gastroenterol Nutr. 2012 Apr; 54(4):446-53.
    View PubMed
  75. Camilleri M, Tremaine WJ. Governance of clinical research. Am J Gastroenterol. 2012 Mar; 107(3):336-8.
    View PubMed
  76. Camilleri M. The role of pharmacogenetics in nonmalignant gastrointestinal diseases. Nat Rev Gastroenterol Hepatol. 2012 Mar; 9(3):173-84. Epub 2012 Feb 07.
    View PubMed
  77. Szarka LA, Camilleri M. Methods for the assessment of small-bowel and colonic transit. Semin Nucl Med. 2012 Mar; 42(2):113-23.
    View PubMed
  78. Jeong ID, Camilleri M, Shin A, Iturrino J, Boldingh A, Busciglio I, Burton D, Ryks M, Rhoten D, Zinsmeister AR. A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Aliment Pharmacol Ther. 2012 Feb 21. [Epub ahead of print]
    View PubMed
  79. Smushkin G, Sathananthan A, Man CD, Zinsmeister AR, Camilleri M, Cobelli C, Rizza RA, Vella A. Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes. J Clin Endocrinol Metab. 2012 Feb; 97(2):589-98. Epub 2011 Nov 16.
    View PubMed
  80. Sathananthan A, Dalla Man C, Zinsmeister AR, Camilleri M, Rodeheffer RJ, Toffolo G, Cobelli C, Rizza RA, Vella A. A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations. Clin Endocrinol (Oxf). 2012 Feb; 76(2):212-9.
    View PubMed
  81. Vazquez-Roque M, Camilleri M. Clarifications about linaclotide. Expert Rev Gastroenterol Hepatol. 2012 Jan; 6(1):15.
    View PubMed
  82. Camilleri M. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome. Clin Pharmacol Ther. 2012 Jan; 91(1):44-59. Epub 2011 Nov 09.
    View PubMed
  83. Camilleri M, Nullens S, Nelsen T. Enteroendocrine and neuronal mechanisms in pathophysiology of acute infectious diarrhea. Dig Dis Sci. 2012 Jan; 57(1):19-27. Epub 2011 Oct 15.
    View PubMed
  84. Camilleri M. Guanylate cyclase C signaling: an intestinal secretory pathway where bugs, genes and new drugs intersect. Genome Med. 2012; 4(6):50. Epub 2012 Jun 26.
    View PubMed
  85. Zucchelli M, Camilleri M, Andreasson AN, Bresso F, Dlugosz A, Halfvarson J, Torkvist L, Schmidt PT, Karling P, Ohlsson B, Duerr RH, Simren M, Lindberg G, Agreus L, Carlson P, Zinsmeister AR, D'Amato M. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut. 2011 Dec; 60(12):1671-7. Epub 2011 Jun 02.
    View PubMed
  86. Camilleri M. Response to sandner-kiesling. Am J Gastroenterol. 2011 Dec; 106(12):2200-1.
    View PubMed
  87. Wong BS, Camilleri M, McKinzie S, Burton D, Graffner H, Zinsmeister AR. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol. 2011 Dec; 106(12):2154-64. Epub 2011 Aug 30.
    View PubMed
  88. Camilleri M, Vazquez-Roque MI, Carlson P, Burton D, Wong BS, Zinsmeister AR. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders. Neurogastroenterol Motil. 2011 Nov; 23(11):995-9, e458. Epub 2011 Aug 24.
    View PubMed
  89. Wong BS, Camilleri M, Busciglio I, Carlson P, Szarka LA, Burton D, Zinsmeister AR. Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome. Gastroenterology. 2011 Nov; 141(5):1638-47.e1-7. Epub 2011 Jul 29.
    View PubMed
  90. Rao AS, Camilleri M, Eckert DJ, Busciglio I, Burton DD, Ryks M, Wong BS, Lamsam J, Singh R, Zinsmeister AR. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol Gastrointest Liver Physiol. 2011 Nov; 301(5):G919-28. Epub 2011 Aug 11.
    View PubMed
  91. Chey WD, Camilleri M, Chang L, Rikner L, Graffner H. A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol. 2011 Oct; 106(10):1803-12. Epub 2011 May 24.
    View PubMed
  92. Camilleri M, Carlson P, McKinzie S, Zucchelli M, D'Amato M, Busciglio I, Burton D, Zinsmeister AR. Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis. Neurogastroenterol Motil. 2011 Oct; 23(10):935-e398. Epub 2011 Jul 14.
    View PubMed
  93. Camilleri M. New treatment options for chronic constipation: mechanisms, efficacy and safety. Can J Gastroenterol. 2011 Oct; 25 Suppl B:29B-35B.
    View PubMed
  94. Iturrino J, Camilleri M, Busciglio I, Burton D, Zinsmeister AR. Effect of the alpha2delta ligand, pregabalin, on colonic sensory and motor functions in healthy adults. Am J Physiol Gastrointest Liver Physiol. 2011 Aug; 301(2):G377-84. Epub 2011 May 19.
    View PubMed
  95. Vazquez-Roque MI, Camilleri M, Vella A, Carlson P, Laugen J, Zinsmeister AR. Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity. Neurogastroenterol Motil. 2011 Jul; 23(7):637-e257. Epub 2011 Apr 07.
    View PubMed
  96. Iturrino J, Camilleri M, Orrock JM. Mega-intestine after subtotal colectomy for constipation. Clin Gastroenterol Hepatol. 2011 Jul; 9(7):A38. Epub 2011 Mar 04.
    View PubMed
  97. Vazquez-Roque M, Camilleri M. VELUSETRAG 5-HT(4) receptor agonist treatment of chronic constipation. Drugs Future. 2011 Jun; 36(6):447-54.
  98. Vazquez-Roque MI, Camilleri M, Carlson P, McKinzie S, Murray JA, Brantner TL, Burton DD, Zinsmeister AR. HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2011 Jun; 23(6):481-7.
    View PubMed
  99. Vazquez-Roque MI, Camilleri M, Vella A, Carlson P, Laugen J, Zinsmeister AR. Association of TCF7L2 allelic variations with gastric function, satiation, and GLP-1 levels. Clin Transl Sci. 2011 Jun; 4(3):183-7.
    View PubMed
  100. Wong BS, Camilleri M, Carlson PJ, Guicciardi ME, Burton D, McKinzie S, Rao AS, Zinsmeister AR, Gores GJ. A Klothobeta variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology. 2011 Jun; 140(7):1934-42. Epub 2011 Mar 09.
    View PubMed
  101. Camilleri M, Breen M, Ryks M, Burton D. Proximal and overall gastric emptying of solids in patients with reduced gastric volume accommodation compared to matched controls. Dig Dis Sci. 2011 Jun; 56(6):1729-34. Epub 2011 Feb 17.
    View PubMed
  102. Vazquez Roque M, Camilleri M. Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation. Expert Rev Gastroenterol Hepatol. 2011 Jun; 5(3):301-10.
    View PubMed
  103. Camilleri M. Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol. 2011 May; 106(5):835-42; quiz 843. Epub 2011 Feb 22.
    View PubMed
  104. Camilleri M. Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipation. Therap Adv Gastroenterol. 2011 May; 4(3):159-63.
    View PubMed
  105. Camilleri M. Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease. Gut. 2011 Apr; 60(4):425-8. Epub 2011 Feb 02.
    View PubMed
  106. Wong BS, Camilleri M. Lubiprostone for the treatment of opioid-induced bowel dysfunction. Expert Opin Pharmacother. 2011 Apr; 12(6):983-90. Epub 2011 Mar 09.
    View PubMed
  107. Breen M, Camilleri M, Burton D, Zinsmeister AR. Performance characteristics of the measurement of gastric volume using single photon emission computed tomography. Neurogastroenterol Motil. 2011 Apr; 23(4):308-15. Epub 2011 Jan 06.
    View PubMed
  108. Camilleri M. LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin. Neurogastroenterol Motil. 2011 Mar; 23(3):193-200. Epub 2010 Dec 15.
    View PubMed
  109. Camilleri M, Rothman M, Ho KF, Etropolski M. Validation of a bowel function diary for assessing opioid-induced constipation. Am J Gastroenterol. 2011 Mar; 106(3):497-506. Epub 2010 Nov 09.
    View PubMed
  110. Rao SS, Camilleri M, Hasler WL, Maurer AH, Parkman HP, Saad R, Scott MS, Simren M, Soffer E, Szarka L. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil. 2011 Jan; 23(1):8-23.
    View PubMed
  111. Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol. 2011 Jan; 9(1):5-12; quiz e7. Epub 2010 Oct 15.
    View PubMed
  112. Wong BS, Camilleri M, Carlson PJ, Guicciardi ME, Burton D, McKinzie S, Rao AS, Zinsmeister AR, Gores GJ. A klotho beta variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology. 2011; 140(7):1934-42.
  113. Lacy BE, Talley NJ, Camilleri M. Functional dyspepsia: time to change clinical trial design? Am J Gastroenterol. 2010 Dec; 105(12):2525-9.
    View PubMed
  114. Camilleri M. LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome. IDrugs. 2010 Dec; 13(12):921-8.
    View PubMed
  115. Rao AS, Wong BS, Camilleri M, Odunsi-Shiyanbade ST, McKinzie S, Ryks M, Burton D, Carlson P, Lamsam J, Singh R, Zinsmeister AR. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology. 2010 Nov; 139(5):1549-58, 1558.e1. Epub 2010 Aug 04.
    View PubMed
  116. Camilleri M, T Odunsi-Shiyanbade S, I Vazquez-Roque M. Response to "Odunsi et al. Results for CM3 Cannot Be Extrapolated to Alginates in General". Obesity (Silver Spring) 2010 Nov; 18(11):2070.
    View PubMed
  117. Camilleri M, Van Outryve MJ, Beyens G, Kerstens R, Robinson P, Vandeplassche L. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies. Aliment Pharmacol Ther. 2010 Nov; 32(9):1113-23. Epub 2010 Sep 16.
    View PubMed
  118. Manabe N, Rao AS, Wong BS, Camilleri M. Emerging pharmacologic therapies for irritable bowel syndrome. Curr Gastroenterol Rep. 2010 Oct; 12(5):408-16.
    View PubMed
  119. Wong BS, Rao AS, Camilleri M, Manabe N, McKinzie S, Busciglio I, Burton DD, Ryks M, Zinsmeister AR. The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health. Aliment Pharmacol Ther. 2010 Oct; 32(7):884-93.
    View PubMed
  120. Camilleri M, Tack JF. Current medical treatments of dyspepsia and irritable bowel syndrome. Gastroenterol Clin North Am. 2010 Sep; 39(3):481-93.
    View PubMed
  121. Camilleri M, Bharucha AE. Behavioural and new pharmacological treatments for constipation: getting the balance right. Gut. 2010 Sep; 59(9):1288-96.
    View PubMed
  122. Sathananthan A, Man CD, Micheletto F, Zinsmeister AR, Camilleri M, Giesler PD, Laugen JM, Toffolo G, Rizza RA, Cobelli C, Vella A. Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study. Diabetes Care. 2010 Sep; 33(9):2074-6.
    View PubMed
  123. Odunsi ST, Vazquez-Roque MI, Camilleri M, Papathanasopoulos A, Clark MM, Wodrich L, Lempke M, McKinzie S, Ryks M, Burton D, Zinsmeister AR. Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity. Obesity (Silver Spring). 2010 Aug; 18(8):1579-84. Epub 2009 Dec 03.
    View PubMed
  124. Spiegel BM, Roberts L, Mody R, Harding G, Kothari-Talwar S, Kahrilas PJ, Camilleri ML, Dabbous O, Revicki DA. The development and validation of a Nocturnal Gastro-oesophageal Reflux Disease Symptom Severity and Impact Questionnaire for adults. Aliment Pharmacol Ther. 2010 Aug; 32(4):591-602. Epub 2010 Jun 02.
    View PubMed
  125. Camilleri M, Thorne NK, Ringel Y, Hasler WL, Kuo B, Esfandyari T, Gupta A, Scott SM, McCallum RW, Parkman HP, Soffer E, Wilding GE, Semler JR, Rao SS. Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil. 2010 Aug; 22(8):874-82, e233. Epub 2010 May 11.
    View PubMed
  126. Papathanasopoulos A, Camilleri M, Carlson PJ, Vella A, Nord SJ, Burton DD, Odunsi ST, Zinsmeister AR. A preliminary candidate genotype-intermediate phenotype study of satiation and gastric motor function in obesity. Obesity (Silver Spring). 2010 Jun; 18(6):1201-11. Epub 2009 Oct 29.
    View PubMed
  127. Rashtak S, Marietta E, Cheng S, Camilleri M, Pittelkow M, David C, Grande J, Murray J. Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background. Lupus. 2010 Jun; 19(7):815-29. Epub 2010 Feb 08.
    View PubMed
  128. Camilleri M. Scintigraphic biomarkers for colonic dysmotility. Clin Pharmacol Ther. 2010 Jun; 87(6):748-53. Epub 2010 Apr 21.
    View PubMed
  129. Manabe N, Wong BS, Camilleri M. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs. 2010 Jun; 19(6):765-75.
    View PubMed
  130. Manabe N, Camilleri M, Rao A, Wong BS, Burton D, Busciglio I, Zinsmeister AR, Haruma K. Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans. Am J Physiol Gastrointest Liver Physiol. 2010 Jun; 298(6):G970-5. Epub 2010 Apr 08.
    View PubMed
  131. Deiteren A, Camilleri M, Bharucha AE, Burton D, McKinzie S, Rao AS, Zinsmeister AR. Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil. 2010 Apr; 22(4):415-23, e95. Epub 2009 Dec 18.
    View PubMed
  132. Manabe N, Wong BS, Camilleri M, Burton D, McKinzie S, Zinsmeister AR. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil. 2010 Mar; 22(3):293-e82. Epub 2009 Dec 21.
    View PubMed
  133. Odunsi ST, Camilleri M, Bharucha AE, Papathanasopoulos A, Busciglio I, Burton D, Zinsmeister AR. Reproducibility and performance characteristics of colonic compliance, tone, and sensory tests in healthy humans. Dig Dis Sci. 2010 Mar; 55(3):709-15. Epub 2009 Mar 17.
    View PubMed
  134. Spiller R, Camilleri M, Longstreth GF. Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes? Clin Gastroenterol Hepatol. 2010 Feb; 8(2):125-9; discussion 129-36.
    View PubMed
  135. Deiteren A, Camilleri M, Burton D, McKinzie S, Rao A, Zinsmeister AR. Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome. Dig Dis Sci. 2010 Feb; 55(2):384-91.
    View PubMed
  136. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, Burton D, Carlson P, Busciglio IA, Lamsam J, Singh R, Zinsmeister AR. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol. 2010 Feb; 8(2):159-65. Epub 2009 Oct 30.
    View PubMed
  137. Bharucha AE, Kulkarni A, Choi KM, Camilleri M, Lempke M, Brunn GJ, Gibbons SJ, Zinsmeister AR, Farrugia G. First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans. Clin Pharmacol Ther. 2010 Feb; 87(2):187-90. Epub 2009 Dec 02.
    View PubMed
  138. Camilleri M, Deiteren A. Prucalopride for constipation. Expert Opin Pharmacother. 2010 Feb; 11(3):451-61.
    View PubMed
  139. Parkman HP, Camilleri M, Farrugia G, McCallum RW, Bharucha AE, Mayer EA, Tack JF, Spiller R, Horowitz M, Vinik AI, Galligan JJ, Pasricha PJ, Kuo B, Szarka LA, Marciani L, Jones K, Parrish CR, Sandroni P, Abell T, Ordog T, Hasler W, Koch KL, Sanders K, Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil. 2010 Feb; 22(2):113-33. Epub 2009 Dec 09.
    View PubMed
  140. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. "Associations among binge eating behavior patterns and gastrointestinal symptoms: A population-based study": Corrigendum. Int J Obes. 2010 Jan; 34(1):214.
  141. Szarka LA, Camilleri M. Stomach dysfunction in diabetes mellitus: emerging technology and pharmacology. J Diabetes Sci Technol. 2010 Jan; 4(1):180-9. Epub 2010 Jan 01.
    View PubMed
  142. Camilleri M, Nadeau A, Lamsam J, Nord SL, Ryks M, Burton D, Sweetser S, Zinsmeister AR, Singh R. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol Motil. 2010 Jan; 22(1):e15-26. Epub 2009 Jul 13
    View PubMed
  143. Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010 Jan; 31(1):11-9.
    View PubMed
  144. Papathanasopoulos A, Camilleri M. Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology. 2010 Jan; 138(1):65-72.e1-2. Epub 2009 Nov 18.
    View PubMed
  145. Camilleri M, Parke DW 2nd. Perspective: Conflict of interest and professional organizations: considerations and recommendations. Acad Med. 2010 Jan; 85(1):85-91.
    View PubMed
  146. Camilleri M. Review article: new receptor targets for medical therapy in irritable bowel syndrome. Aliment Pharmacol Ther. 2010 Jan; 31(1):35-46.
    View PubMed
  147. Ravi K, Bharucha AE, Camilleri M, Rhoten D, Bakken T, Zinsmeister AR. Phenotypic variation of colonic motor functions in chronic constipation. Gastroenterology. 2010 Jan; 138(1):89-97. Epub 2009 Aug 04.
    View PubMed
  148. Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio I, Burton D, Zucchelli M, D'Amato M. Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders. Gastroenterology. 2010 Jan; 138(1):98-107.e4. Epub 2009 Sep 02.
    View PubMed
  149. Manini ML, Camilleri M, Goldberg M, Sweetser S, McKinzie S, Burton D, Wong S, Kitt MM, Li YP, Zinsmeister AR. Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil. 2010 Jan; 22(1):42-9, e7-8. Epub 2009 Aug 18.
    View PubMed
  150. Wong BS, Manabe N, Camilleri M. Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation. Clin Exp Gastroenterol. 2010; 3:49-56. Epub 2010 May 24.
    View PubMed
  151. Camilleri M, Andresen V. Current and novel therapeutic options for irritable bowel syndrome management. Dig Liver Dis. 2009 Dec; 41(12):854-62. Epub 2009 Aug 08.
    View PubMed
  152. Camilleri M, Beyens G, Kerstens R, Robinson P, Vandeplassche L. Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study. Neurogastroenterol Motil. 2009 Dec; 21(12):1256-e117. Epub 2009 Sep 09.
    View PubMed
  153. Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report. Gastroenterology. 2009 Dec; 137(6):1944-53.e1-3. Epub 2009 Aug 23.
    View PubMed
  154. Manabe N, Cremonini F, Camilleri M, Sandborn WJ, Burton DD. Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers. Aliment Pharmacol Ther. 2009 Nov 1; 30(9):930-6. Epub 2009 Aug 12.
    View PubMed
  155. Camilleri M. Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogenetics. Dig Dis Sci. 2009 Nov; 54(11):2318-24. Epub 2009 Aug 05.
    View PubMed
  156. Camilleri M. Do the Symptom-Based, Rome Criteria of Irritable Bowel Syndrome Lead to Better Diagnosis and Treatment Outcomes? The Con Argument. Clin Gastroenterol Hepatol. 2009 Oct 20; 8(2):129. [Epub ahead of print]
    View PubMed
  157. Keller J, Andresen V, Wolter J, Layer P, Camilleri M. Influence of clinical parameters on the results of 13C-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil. 2009 Oct; 21(10):1039-e83. Epub 2009 Jun 22.
    View PubMed
  158. Revicki DA, Camilleri M, Kuo B, Norton NJ, Murray L, Palsgrove A, Parkman HP. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther. 2009 Sep 15; 30(6):670-80. Epub 2009 Jun 25.
    View PubMed
  159. Gathaiya N, Locke GR 3rd, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil. 2009 Sep; 21(9):922-e69. Epub 2009 Jun 02.
    View PubMed
  160. Camilleri M. Peripheral mechanisms in the control of appetite and related experimental therapies in obesity. Regul Pept. 2009 Aug 7; 156(1-3):24-7. Epub 2009 May 03.
    View PubMed
  161. Szarka LA, Camilleri M. Gastric emptying. Clin Gastroenterol Hepatol. 2009 Aug; 7(8):823-7. Epub 2009 Apr 24.
    View PubMed
  162. Izzo AA, Camilleri M. Cannabinoids in intestinal inflammation and cancer. Pharmacol Res. 2009 Aug; 60(2):117-25. Epub 2009 Mar 18.
    View PubMed
  163. Camilleri M, Nadeau A, Tremaine WJ, Lamsam J, Burton D, Odunsi S, Sweetser S, Singh R. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil. 2009 Jul; 21(7):734-e43. Epub 2009 Mar 13.
    View PubMed
  164. Odunsi ST, Camilleri M, Szarka LA, Zinsmeister AR. Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids. Neurogastroenterol Motil. 2009 Jul; 21(7):706-e38. Epub 2009 Feb 27.
    View PubMed
  165. Bernard CE, Gibbons SJ, Gomez-Pinilla PJ, Lurken MS, Schmalz PF, Roeder JL, Linden D, Cima RR, Dozois EJ, Larson DW, Camilleri M, Zinsmeister AR, Pozo MJ, Hicks GA, Farrugia G. Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil. 2009 Jul; 21(7):746-e46. Epub 2009 Feb 08.
    View PubMed
  166. Sweetser S, Camilleri M, Linker Nord SJ, Burton DD, Castenada L, Croop R, Tong G, Dockens R, Zinsmeister AR. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? Am J Physiol Gastrointest Liver Physiol. 2009 Jun; 296(6):G1299-306. Epub 2009 Apr 02.
    View PubMed
  167. Camilleri M, Papathanasopoulos A, Odunsi ST. Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. 2009 Jun; 6(6):343-52.
    View PubMed
  168. Odunsi ST, Camilleri M. Selected interventions in nuclear medicine: gastrointestinal motor functions. Semin Nucl Med. 2009 May; 39(3):186-94.
    View PubMed
  169. Camilleri M, Busciglio I, Carlson P, McKinzie S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Pharmacogenetics of low dose clonidine in irritable bowel syndrome. Neurogastroenterol Motil. 2009 Apr; 21(4):399-410.
    View PubMed
  170. Camilleri M. Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut? J Pediatr Gastroenterol Nutr. 2009 Apr; 48 Suppl 2:S46-8.
    View PubMed
  171. Manini ML, Burton DD, Meixner DD, Eckert DJ, Callstrom M, Schmit G, El-Youssef M, Camilleri M. Feasibility and application of 3-dimensional ultrasound for measurement of gastric volumes in healthy adults and adolescents. J Pediatr Gastroenterol Nutr. 2009 Mar; 48(3):287-93.
    View PubMed
  172. Camilleri M. The stomach in diabetes: from villain to ally. Clin Gastroenterol Hepatol. 2009 Mar; 7(3):285-7. Epub 2008 Nov 06.
    View PubMed
  173. Camilleri M, Toouli J, Herrera MF, Kow L, Pantoja JP, Billington CJ, Tweden KS, Wilson RR, Moody FG. Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device. Surg Obes Relat Dis. 2009 Mar-Apr; 5(2):224-9; discussion 229-30. Epub 2008 Sep 12.
    View PubMed
  174. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond). 2009 Mar; 33(3):342-53. Epub 2009 Jan 13.
    View PubMed
  175. Bharucha AE, Camilleri M, Forstrom LA, Zinsmeister AR. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol (Oxf). 2009 Mar; 70(3):415-20. Epub 2008 Aug 22.
    View PubMed
  176. Floyd BN, Camilleri M, Busciglio I, Sweetser S, Burton D, Wong GY, Kell S, Khanna S, Hwang S, Zinsmeister AR. Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers. Neurogastroenterol Motil. 2009 Mar; 21(3):281-90. Epub 2008 Sep 23.
    View PubMed
  177. Szarka LA, Camilleri M. Methods for measurement of gastric motility. Am J Physiol Gastrointest Liver Physiol. 2009 Mar; 296(3):G461-75. Epub 2009 Jan 15.
    View PubMed
  178. Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio I, Burton D, Zaki EA, Boles RG. Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am J Physiol Gastrointest Liver Physiol. 2009 Mar; 296(3):G510-6. Epub 2009 Jan 15.
    View PubMed
  179. Camilleri M. Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2009 Feb; 16(1):53-9.
    View PubMed
  180. Cremonini F, Camilleri M, Zinsmeister AR, Herrick LM, Beebe T, Talley NJ. Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil. 2009 Feb; 21(2):128-35. Epub 2008 Sep 18.
    View PubMed
  181. Sweetser S, Busciglio IA, Camilleri M, Bharucha AE, Szarka LA, Papathanasopoulos A, Burton DD, Eckert DJ, Zinsmeister AR. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Am J Physiol Gastrointest Liver Physiol. 2009 Feb; 296(2):G295-301. Epub 2008 Nov 25.
    View PubMed
  182. Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2009 Jan 1; 31(1):11-9.
    View PubMed
  183. Camilleri M. Review article: new receptor targets for medical therapy in irritable bowel syndrome. Aliment Pharmacol Ther. 2009 Jan 1; 31(1):35-46.
    View PubMed
  184. Fidler J, Bharucha AE, Camilleri M, Camp J, Burton D, Grimm R, Riederer SJ, Robb RA, Zinsmeister AR. Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans. Neurogastroenterol Motil. 2009 Jan; 21(1):42-51. Epub 2008 Oct 06.
    View PubMed
  185. Dalla Man C, Bock G, Giesler PD, Serra DB, Ligueros Saylan M, Foley JE, Camilleri M, Toffolo G, Cobelli C, Rizza RA, Vella A. Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes. Diabetes Care. 2009 Jan; 32(1):14-8. Epub 2008 Oct 17.
    View PubMed
  186. Gibbons SJ, De Giorgio R, Faussone Pellegrini MS, Garrity-Park MM, Miller SM, Schmalz PF, Young-Fadok TM, Larson DW, Dozois EJ, Camilleri M, Stanghellini V, Szurszewski JH, Farrugia G. Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil. 2009 Jan; 21(1):85-93. Epub 2008 Sep 16.
    View PubMed
  187. Camilleri M, Chang L. Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. Gastroenterology. 2008 Dec; 135(6):1877-91. Epub 2008 Oct 09.
    View PubMed
  188. Camilleri M. Drug development and IBS drugs: experience from the past, current challenges, and proposal for the future. Curr Opin Pharmacol. 2008 Dec; 8(6):671-6. Epub 2008 Jul 09.
    View PubMed
  189. Camilleri M, Bharucha AE, di Lorenzo C, Hasler WL, Prather CM, Rao SS, Wald A. American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil. 2008 Dec; 20(12):1269-82.
    View PubMed
  190. Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Deacon CF, Foley JE, Rizza RA, Camilleri M. The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study. Clin Endocrinol (Oxf). 2008 Nov; 69(5):737-44. Epub 2008 Mar 10.
    View PubMed
  191. Grudell AB, Sweetser S, Camilleri M, Eckert DJ, Vazquez-Roque MI, Carlson PJ, Burton DD, Braddock AE, Clark MM, Graszer KM, Kalsy SA, Zinsmeister AR. A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology. 2008 Oct; 135(4):1142-54. Epub 2008 Jul 16.
    View PubMed
  192. Camilleri M. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. J Clin Gastroenterol. 2008 Sep; 42 Suppl 3 Pt 1:S123-5.
    View PubMed
  193. Bharucha AE, Charkoudian N, Andrews CN, Camilleri M, Sletten D, Zinsmeister AR, Low PA. Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans. Am J Physiol Regul Integr Comp Physiol. 2008 Sep; 295(3):R874-80. Epub 2008 Jul 02.
    View PubMed
  194. Camilleri M. Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation. Neurogastroenterol Motil. 2008 Sep; 20(9):971-9.
    View PubMed
  195. Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2008 Aug; 103(8):2043-50.
    View PubMed
  196. Bharucha AE, Skaar T, Andrews CN, Camilleri M, Philips S, Seide B, Burton D, Baxter K, Zinsmeister AR. Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects. Neurogastroenterol Motil. 2008 Aug; 20(8):891-9. Epub 2008 Apr 16.
    View PubMed
  197. Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut. 2008 Aug; 57(8):1140-55. Epub 2008 Apr 08.
    View PubMed
  198. Camilleri M. New therapeutic approaches in irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2008 Aug; 12 Suppl 1:139-40.
    View PubMed
  199. Camilleri M, Busciglio I, Carlson P, McKinzie S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Candidate genes and sensory functions in health and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2008 Aug; 295(2):G219-25. Epub 2008 May 29.
    View PubMed
  200. Bharucha AE, Low PA, Camilleri M, Burton D, Gehrking TL, Zinsmeister AR. Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. Clin Auton Res. 2008 Aug; 18(4):194-202. Epub 2008 Jul 11.
    View PubMed
  201. Delgado-Aros S, Camilleri M, Garcia MA, Burton D, Busciglio I. High body mass alters colonic sensory-motor function and transit in humans. Am J Physiol Gastrointest Liver Physiol. 2008 Aug; 295(2):G382-8. Epub 2008 Jul 10.
    View PubMed
  202. Camilleri M, McKinzie S, Busciglio I, Low PA, Sweetser S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008 Jul; 6(7):772-81. Epub 2008 May 05.
    View PubMed
  203. Andresen V, Camilleri M. Linaclotide acetate guanylate cyclase C receptor agonist treatment of irritable bowel syndrome treatment of constipation. Drugs Future. 2008 Jul; 33(7):570-6.
    View PubMed
  204. Talley NJ, Choung RS, Camilleri M, Dierkhising RA, Zinsmeister AR. Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther. 2008 Jun 1; 27(11):1122-31. Epub 2008 Mar 07.
    View PubMed
  205. Szarka LA, Camilleri M, Vella A, Burton D, Baxter K, Simonson J, Zinsmeister AR. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol. 2008 Jun; 6(6):635-643.e1. Epub 2008 Apr 14.
    View PubMed
  206. Camilleri M, Toouli J, Herrera MF, Kulseng B, Kow L, Pantoja JP, Marvik R, Johnsen G, Billington CJ, Moody FG, Knudson MB, Tweden KS, Vollmer M, Wilson RR, Anvari M. Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery. 2008 Jun; 143(6):723-31. Epub 2008 May 09.
    View PubMed
  207. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med. 2008 May 29; 358(22):2344-54.
    View PubMed
  208. Sweetser S, Camilleri M. Clinical challenges and images in GI. Hindgut dysgenesis with megacolon. Gastroenterology. 2008 May; 134(5):1293, 1635.
    View PubMed
  209. Andresen V, Montori VM, Keller J, West CP, Layer P, Camilleri M. Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol. 2008 May; 6(5):545-55. Epub 2008 Jan 31.
    View PubMed
  210. Grudell AB, Camilleri M, Jensen KL, Foxx-Orenstein AE, Burton DD, Ryks MD, Baxter KL, Cox DS, Dukes GE, Kelleher DL, Zinsmeister AR. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health. Am J Physiol Gastrointest Liver Physiol. 2008 May; 294(5):G1114-9. Epub 2008 Mar 27.
    View PubMed
  211. Vella A, Camilleri M. Pharmacogenetics: potential role in the treatment of diabetes and obesity. Expert Opin Pharmacother. 2008 May; 9(7):1109-19.
    View PubMed
  212. Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ, Nehra V, Talley NJ. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg. 2008 Apr; 18(4):401-7. Epub 2008 Feb 20.
    View PubMed
  213. Floyd BN, Camilleri M, Andresen V, Esfandyari T, Busciglio I, Zinsmeister AR. Comparison of mathematical methods for calculating colonic compliance in humans: power exponential, computer-based and manual linear interpolation models. Neurogastroenterol Motil. 2008 Apr; 20(4):330-5. Epub 2007 Oct 25.
    View PubMed
  214. Camilleri M, Cowen T, Koch TR. Enteric neurodegeneration in ageing. Neurogastroenterol Motil. 2008 Apr; 20(4):418-29.
    View PubMed
  215. Grudell AB, Camilleri M, Carlson P, Gorman H, Ryks M, Burton D, Baxter K, Zinsmeister AR. An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions. Neurogastroenterol Motil. 2008 Mar; 20(3):213-9. Epub 2007 Oct 17.
    View PubMed
  216. Camilleri M, Cowen T, Koch TR. Enteric neurodegeneration in ageing. Neurogastroenterol Motil. 2008 Mar; 20(3):185-96.
    View PubMed
  217. Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T, Nusynowitz ML, Parkman HP, Shreve P, Szarka LA, Snape WJ Jr, Ziessman HA, American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008 Mar; 103(3):753-63. Epub 2007 Nov 19.
    View PubMed
  218. Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T, Nusynowitz ML, Parkman HP, Shreve P, Szarka LA, Snape WJ Jr, Ziessman HA, American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol. 2008 Mar; 36(1):44-54. Epub 2008 Feb 20.
    View PubMed
  219. Aerssens J, Camilleri M, Talloen W, Thielemans L, Gohlmann HW, Van Den Wyngaert I, Thielemans T, De Hoogt R, Andrews CN, Bharucha AE, Carlson PJ, Busciglio I, Burton DD, Smyrk T, Urrutia R, Coulie B. Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008 Feb; 6(2):194-205.
    View PubMed
  220. Camilleri M, Carlson P, McKinzie S, Grudell A, Busciglio I, Burton D, Baxter K, Ryks M, Zinsmeister AR. Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation. Am J Physiol Gastrointest Liver Physiol. 2008 Jan; 294(1):G13-9. Epub 2007 Oct 25.
    View PubMed
  221. Camilleri M, Andresen V, Keller J, Layer P, Montori V. Pharmacological and non-pharmacological interventions for symptomatic gastroparesis. Cochrane Database Syst Rev. 2008; (2):CD007116.
    View PubMed
  222. Mariani A, Camilleri M, Petersen IA, Ward EM, Farrugia G, Kelly DG, Podratz KC. Audit of suspected chronic intestinal pseudo-obstruction in patients with gynecologic cancer. Eur J Gynaecol Oncol. 2008; 29(6):578-82.
    View PubMed
  223. Camilleri M, Saito YA. Pharmacogenomics in gastrointestinal disorders. Methods Mol Biol. 2008; 448:395-412.
    View PubMed
  224. Choi KM, Zhu J, Stoltz GJ, Vernino S, Camilleri M, Szurszewski JH, Gibbons SJ, Farrugia G. Determination of gastric emptying in nonobese diabetic mice. Am J Physiol Gastrointest Liver Physiol. 2007 Nov; 293(5):G1039-45. Epub 2007 Sep 20.
    View PubMed
  225. Szarka LA, Camilleri M, Burton D, Fox JC, McKinzie S, Stanislav T, Simonson J, Sullivan N, Zinsmeister AR. Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2007 Nov; 5(11):1268-75. Epub 2007 Sep 27.
    View PubMed
  226. Beebe TJ, Talley NJ, Camilleri M, Jenkins SM, Anderson KJ, Locke GR 3rd. The HIPAA authorization form and effects on survey response rates, nonresponse bias, and data quality: a randomized community study. Med Care. 2007 Oct; 45(10):959-65.
    View PubMed
  227. Foxx-Orenstein AE, Camilleri M, Szarka LA, McKinzie S, Burton D, Thomforde G, Baxter K, Zinsmeister AR. Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial. Neurogastroenterol Motil. 2007 Oct; 19(10):821-30. Epub 2007 May 21.
    View PubMed
  228. Camilleri M. Functional dyspepsia: mechanisms of symptom generation and appropriate management of patients. Gastroenterol Clin North Am. 2007 Sep; 36(3):649-64, xi-x.
    View PubMed
  229. Andresen V, Camilleri M, Busciglio IA, Grudell A, Burton D, McKinzie S, Foxx-Orenstein A, Kurtz CB, Sharma V, Johnston JM, Currie MG, Zinsmeister AR. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology. 2007 Sep; 133(3):761-8. Epub 2007 Jul 03.
    View PubMed
  230. Tremaine WJ, Camilleri M. Ethical issues concerning therapeutic studies in inflammatory bowel disease. Inflamm Bowel Dis. 2007 Sep; 13(9):1141-5.
    View PubMed
  231. Andrews CN, Bharucha AE, Camilleri M, Low PA, Seide BM, Burton DD, Nickander KK, Baxter KL, Zinsmeister AR. Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans. Neurogastroenterol Motil. 2007 Sep; 19(9):716-23.
    View PubMed
  232. Houghton LA, Cremonini F, Camilleri M, Busciglio I, Fell C, Cox V, Alpers DH, Dewit OE, Dukes GE, Gray E, Lea R, Zinsmeister AR, Whorwell PJ. Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans. Neurogastroenterol Motil. 2007 Sep; 19(9):732-43.
    View PubMed
  233. Camilleri M. Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications. Neurogastroenterol Motil. 2007 Aug; 19 Suppl 2:40-5.
    View PubMed
  234. Camilleri M, Gorman H. Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil. 2007 Jul; 19(7):545-52.
    View PubMed
  235. Vazquez Roque MI, Camilleri M, Clark MM, Tepoel DA, Jensen MD, Graszer KM, Kalsy SA, Burton DD, Baxter KL, Zinsmeister AR. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. Clin Gastroenterol Hepatol. 2007 Jul; 5(7):829-37. Epub 2007 Jun 04.
    View PubMed
  236. Esfandyari T, Camilleri M, Busciglio I, Burton D, Baxter K, Zinsmeister AR. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am J Physiol Gastrointest Liver Physiol. 2007 Jul; 293(1):G137-45. Epub 2007 Mar 29.
    View PubMed
  237. Camilleri M, Grudell AB. Appetite and obesity: a gastroenterologist's perspective. Neurogastroenterol Motil. 2007 May; 19(5):333-41.
    View PubMed
  238. Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007 May; 5(5):534-40. Epub 2007 Apr 11.
    View PubMed
  239. Camilleri M, Cortese DA. Managing conflict of interest in clinical practice. Mayo Clin Proc. 2007 May; 82(5):607-14.
    View PubMed
  240. Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Dunning BE, Foley JE, Rizza RA, Camilleri M. Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes. Diabetes. 2007 May; 56(5):1475-80. Epub 2007 Feb 15.
    View PubMed
  241. Andrews CN, Bharucha AE, Camilleri M, Low PA, Seide B, Burton D, Baxter K, Zinsmeister AR. Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults. Am J Physiol Gastrointest Liver Physiol. 2007 May; 292(5):G1359-65. Epub 2007 Feb 08.
    View PubMed
  242. Camilleri M, Dubnansky EC, Rustgi AK. Conflicts of interest and disclosures in publications. Clin Gastroenterol Hepatol. 2007 Mar; 5(3):268-73.
    View PubMed
  243. Choung RS, Talley NJ, Peterson J, Camilleri M, Burton D, Harmsen WS, Zinsmeister AR. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil. 2007 Mar; 19(3):180-7.
    View PubMed
  244. Camilleri M. Clinical practice. Diabetic gastroparesis. N Engl J Med. 2007 Feb 22; 356(8):820-9.
    View PubMed
  245. Grudell AB, Camilleri M. The role of peptide YY in integrative gut physiology and potential role in obesity. Curr Opin Endocrinol Diabetes Obes. 2007 Feb; 14(1):52-7.
    View PubMed
  246. Camilleri M. Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment? Neurogastroenterol Motil. 2007 Feb; 19(2):77-84.
    View PubMed
  247. Camilleri M, Andrews CN, Bharucha AE, Carlson PJ, Ferber I, Stephens D, Smyrk TC, Urrutia R, Aerssens J, Thielemans L, Gohlmann H, van den Wyngaert I, Coulie B. Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology. 2007 Jan; 132(1):17-25. Epub 2006 Nov 17.
    View PubMed
  248. Camilleri M, Vazquez-Roque MI, Burton D, Ford T, McKinzie S, Zinsmeister AR, Druzgala P. Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans. Neurogastroenterol Motil. 2007 Jan; 19(1):30-8.
    View PubMed
  249. Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 2007 Jan; 19(Suppl 1):62-88.
    View PubMed
  250. Dalla Man C, Camilleri M, Cobelli C. A system model of oral glucose absorption: validation on gold standard data. IEEE Trans Biomed Eng. 2006 Dec; 53(12 Pt 1):2472-8.
    View PubMed
  251. Camilleri M. Gastroenterology and hepatology clinical research update: 2005-2006. Clin Gastroenterol Hepatol. 2006 Dec; 4(12):1428-33. Epub 2006 Sep 01.
    View PubMed
  252. Vazquez Roque MI, Camilleri M, Stephens DA, Jensen MD, Burton DD, Baxter KL, Zinsmeister AR. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology. 2006 Dec; 131(6):1717-24. Epub 2006 Oct 15.
    View PubMed
  253. Xue L, Camilleri M, Locke GR 3rd, Schuurkes JA, Meulemans A, Coulie BJ, Szurszewski JH, Farrugia G. Serotonergic modulation of murine fundic tone. Am J Physiol Gastrointest Liver Physiol. 2006 Dec; 291(6):G1180-6. Epub 2006 Jul 27.
    View PubMed
  254. Camilleri M. Is there a role for probiotics in irritable bowel syndrome? Dig Liver Dis. 2006 Dec; 38 Suppl 2:S266-9.
    View PubMed
  255. Chial HJ, Camilleri M. A twenty-one-year-old college student with postprandial regurgitation and weight loss. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1314-7. Epub 2006 Oct 23.
    View PubMed
  256. Cremonini F, Camilleri M, Vazquez Roque M, McKinzie S, Burton D, Baxter K, Zinsmeister AR. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Gastroenterology. 2006 Nov; 131(5):1431-9. Epub 2006 Sep 20.
    View PubMed
  257. Grudell AB, Camilleri M, Burton DD, Stephens DA. Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study. Aliment Pharmacol Ther. 2006 Oct 1; 24(7):1037-43.
    View PubMed
  258. Gonenne J, Esfandyari T, Camilleri M, Burton DD, Stephens DA, Baxter KL, Zinsmeister AR, Bharucha AE. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil. 2006 Oct; 18(10):911-8.
    View PubMed
  259. Saito YA, Camilleri M. Clinical application of pharmacogenetics in gastrointestinal diseases. Expert Opin Pharmacother. 2006 Oct; 7(14):1857-69.
    View PubMed
  260. Talley NJ, Camilleri M, Burton D, Thomforde G, Koch K, Rucker MJ, Peterson J, Zinsmeister AR, Earnest DL. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Aliment Pharmacol Ther. 2006 Sep 1; 24(5):859-67.
    View PubMed
  261. Esfandyari T, Camilleri M, Ferber I, Burton D, Baxter K, Zinsmeister AR. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil. 2006 Sep; 18(9):831-8.
    View PubMed
  262. Camilleri M. New imaging in neurogastroenterology: an overview. Neurogastroenterol Motil. 2006 Sep; 18(9):805-12.
    View PubMed
  263. Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil. 2006 Aug; 18(8):595-607.
    View PubMed
  264. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology. 2006 Aug; 131(2):640-58.
    View PubMed
  265. Camilleri M. Management of patients with chronic abdominal pain in clinical practice. Neurogastroenterol Motil. 2006 Jul; 18(7):499-506.
    View PubMed
  266. Andresen V, Camilleri M, Kim HJ, Stephens DA, Carlson PJ, Talley NJ, Saito YA, Urrutia R, Zinsmeister AR. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology. 2006 Jun; 130(7):1985-94.
    View PubMed
  267. Park MI, Camilleri M. Gastroparesis: clinical update. Am J Gastroenterol. 2006 May; 101(5):1129-39.
    View PubMed
  268. Camilleri M, Bharucha AE, Ueno R, Burton D, Thomforde GM, Baxter K, McKinzie S, Zinsmeister AR. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2006 May; 290(5):G942-7.
    View PubMed
  269. Andresen V, Camilleri M. Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia. Neurogastroenterol Motil. 2006 May; 18(5):346-53.
    View PubMed
  270. Andresen V, Camilleri M. Challenges in drug development for functional gastrointestinal disorders. Part II: visceral pain. Neurogastroenterol Motil. 2006 May; 18(5):354-60.
    View PubMed
  271. Skoog SM, Bharucha AE, Camilleri M, Burton DD, Zinsmeister AR. Effects of an osmotically active agent on colonic transit. Neurogastroenterol Motil. 2006 Apr; 18(4):300-6.
    View PubMed
  272. Camilleri M, Bueno L, de Ponti F, Fioramonti J, Lydiard RB, Tack J. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. Gastroenterology. 2006 Apr; 130(5):1421-34.
    View PubMed
  273. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006 Apr; 130(5):1466-79.
    View PubMed
  274. Camilleri CE, Carlson PJ, Camilleri M, Castillo EJ, Locke GR 3rd, Geno DM, Stephens DA, Zinsmeister AR, Urrutia R. A study of candidate genotypes associated with dyspepsia in a U.S. community. Am J Gastroenterol. 2006 Mar; 101(3):581-92. Epub 2006 Feb 08.
    View PubMed
  275. Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol. 2006 Mar; 40(3):264-9.
    View PubMed
  276. Floch MH, Madsen KK, Jenkins DJ, Guandalini S, Katz JA, Onderdonk A, Walker WA, Fedorak RN, Camilleri M. Recommendations for probiotic use. J Clin Gastroenterol. 2006 Mar; 40(3):275-8.
    View PubMed
  277. Xue L, Locke GR, Camilleri M, Schuurkes JA, Meulemans A, Coulie BJ, Szurszewski JH, Farrugia G. Effect of modulation of serotonergic, cholinergic, and nitrergic pathways on murine fundic size and compliance measured by ultrasonomicrometry. Am J Physiol Gastrointest Liver Physiol. 2006 Jan; 290(1):G74-82. Epub 2005 Sep 15.
    View PubMed
  278. Park MI, Ferber I, Camilleri M, Allenby K, Trillo R, Burton D, Zinsmeister AR. Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil. 2006 Jan; 18(1):28-36.
    View PubMed
  279. Andresen V, Camilleri M. Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs. 2006; 66(8):1073-88.
    View PubMed
  280. Schiller LR, Camilleri M. Lubiprostone: profile report. Drugs and Therapy Perspectives. 2006; 22(9):5-6.
    View PubMed
  281. Camilleri M. GIH clinical research update: 2004-2005. Clin Gastroenterol Hepatol. 2005 Dec; 3(12):1161-6.
    View PubMed
  282. Cremonini F, Houghton LA, Camilleri M, Ferber I, Fell C, Cox V, Castillo EJ, Alpers DH, Dewit OE, Gray E, Lea R, Zinsmeister AR, Whorwell PJ. Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility. Neurogastroenterology & Motility. 2005 Dec; 17(6):810-20.
    View PubMed
  283. Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, Zinsmeister AR. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil. 2005 Oct; 17(5):687-96.
    View PubMed
  284. Delgado-Aros S, Camilleri M, Castillo EJ, Cremonini F, Stephens D, Ferber I, Baxter K, Burton D, Zinsmeister AR. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study. Clin Gastroenterol Hepatol. 2005 Oct; 3(10):997-1006.
    View PubMed
  285. Camilleri M, Gamble GL, Kopecky SL, Wood MB, Hockema ML. Principles and process in the development of the Mayo Clinic's individual and institutional conflict of interest policy. Mayo Clin Proc. 2005 Oct; 80(10):1340-6.
    View PubMed
  286. Cremonini F, Camilleri M, Gonenne J, Stephens D, Oenning L, Baxter K, Foxx-Orenstein A, Burton D. Effect of somatostatin analog on postprandial satiation in obesity. Obes Res. 2005 Sep; 13(9):1572-9.
    View PubMed
  287. Gonenne J, Camilleri M, Ferber I, Burton D, Baxter K, Keyashian K, Foss J, Wallin B, Du W, Zinsmeister AR. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Clin Gastroenterol Hepatol. 2005 Aug; 3(8):784-91.
    View PubMed
  288. Burton DD, Kim HJ, Camilleri M, Stephens DA, Mullan BP, O'Connor MK, Talley NJ. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol. 2005 Aug; 289(2):G261-6.
    View PubMed
  289. Camilleri M. Pharmacogenomics and functional gastrointestinal disorders. Pharmacogenomics. 2005 Jul; 6(5):491-501.
    View PubMed
  290. Nickander KK, Carlson PJ, Urrutia RA, Camilleri M, Low PA. A screen of candidate genes and influence of beta2-adrenergic receptor genotypes in postural tachycardia syndrome. Auton Neurosci. 2005 Jun 15; 120(1-2):97-103.
    View PubMed
  291. Park MI, Camilleri M. Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. Gastroenterol Clin North Am. 2005 Jun; 34(2):305-17.
    View PubMed
  292. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005 Jun; 3(6):543-52.
    View PubMed
  293. Delgado-Aros S, Camilleri M. Visceral hypersensitivity. J Clin Gastroenterol. 2005 May-Jun; 39(5 Suppl 3):S194-203; discussion S210.
    View PubMed
  294. Chitkara DK, Camilleri M, Zinsmeister AR, Burton D, El-Youssef M, Freese D, Walker L, Stephens D. Gastric sensory and motor dysfunction in adolescents with functional dyspepsia. J Pediatr. 2005 Apr; 146(4):500-5.
    View PubMed
  295. Camilleri M. Alvimopan, a selective peripherally acting mu-opioid antagonist. Neurogastroenterol Motil. 2005 Apr; 17(2):157-65.
    View PubMed
  296. Cremonini F, Camilleri M, McKinzie S, Carlson P, Camilleri CE, Burton D, Thomforde G, Urrutia R, Zinsmeister AR. Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study. Am J Gastroenterol. 2005 Mar; 100(3):652-63.
    View PubMed
  297. Park MI, Camilleri M. Gastric motor and sensory functions in obesity. Obes Res. 2005 Mar; 13(3):491-500.
    View PubMed
  298. Gonenne J, Castillo EJ, Camilleri M, Burton D, Thomforde GM, Baxter KL, Zinsmeister AR. Does the nutrient drink test accurately predict postprandial gastric volume in health and community dyspepsia? Neurogastroenterol Motil. 2005 Feb; 17(1):44-50.
    View PubMed
  299. Talley NJ, Camilleri M, Chitkara DK, Bouras E, Locke GR 3rd, Burton D, Rucker MJ, Thapa P, Zinsmeister AR. Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: a randomized, double-blind, placebo-controlled study. Digestion. 2005; 72(2-3):97-103. Epub 2005 Sep 16.
    View PubMed
  300. Camilleri M. Etiology and pathophysiology of irritable bowel syndrome and chronic constipation. Advanced Studies in Medicine. 2005; 5(10 B):S955-64.
    View PubMed
  301. Bouras EP, Burton DD, Camilleri M, Stephens DA, Thomforde GM. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans. Neurogastroenterol Motil. 2004 Dec; 16(6):729-35.
    View PubMed
  302. Delgado-Aros S, Camilleri M, Cremonini F, Ferber I, Stephens D, Burton DD. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology. 2004 Dec; 127(6):1685-94.
    View PubMed
  303. Castillo EJ, Camilleri M, Locke GR, Burton DD, Stephens DA, Geno DM, Zinsmeister AR. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol. 2004 Nov; 2(11):985-96.
    View PubMed
  304. De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil. 2004 Oct; 16(5):515-31.
    View PubMed
  305. De Schepper H, Camilleri M, Cremonini F, Foxx-Orenstein A, Burton D. Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans. Neurogastroenterol Motil. 2004 Oct; 16(5):567-73.
    View PubMed
  306. Camilleri M, McKinzie S, Fox J, Foxx-Orenstein A, Burton D, Thomforde G, Baxter K, Zinsmeister AR. Effect of renzapride on transit in constipation-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004 Oct; 2(10):895-904.
    View PubMed
  307. Hicks GA, Dehaven-Hudkins DL, Camilleri M. Opiates in the control of gastrointestinal tract function: current knowledge and new avenues for research. Neurogastroenterol Motil. 2004 Oct; 16(Suppl 2):67-70.
    View PubMed
  308. Delgado-Aros S, Locke GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ. Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study. Am J Gastroenterol. 2004 Sep; 99(9):1801-6.
    View PubMed
  309. Castillo EJ, Delgado-Aros S, Camilleri M, Burton D, Stephens D, O'Connor-Semmes R, Walker A, Shachoy-Clark A, Zinsmeister AR. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2004 Aug; 287(2):G363-9.
    View PubMed
  310. De Schepper HU, Cremonini F, Park MI, Camilleri M. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil. 2004 Aug; 16(4):383-94.
    View PubMed
  311. Chitkara DK, Bredenoord AJ, Cremonini F, Delgado-Aros S, Smoot RL, El-Youssef M, Freese D, Camilleri M. The role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipation. Am J Gastroenterol. 2004 Aug; 99(8):1579-84.
    View PubMed
  312. Vella A, Camilleri M, Rizza RA. The gastrointestinal tract and glucose tolerance. Curr Opin Clin Nutr Metab Care. 2004 Jul; 7(4):479-84.
    View PubMed
  313. Kim HJ, Camilleri M, Carlson PJ, Cremonini F, Ferber I, Stephens D, McKinzie S, Zinsmeister AR, Urrutia R. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut. 2004 Jun; 53(6):829-37.
    View PubMed
  314. De Schepper HU, Cremonini F, Chitkara D, Camilleri M. Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil. 2004 Jun; 16(3):275-85.
    View PubMed
  315. Camilleri M. Advances in pharmacological treatments of IBS. J Pediatr Gastroenterol Nutr. 2004 Jun; 39 Suppl 3:S766-7.
    View PubMed
  316. Camilleri M. Treating irritable bowel syndrome: overview, perspective and future therapies. Br J Pharmacol. 2004 Apr; 141(8):1237-48. Epub 2004 Mar 22.
    View PubMed
  317. Camilleri M, Talley NJ. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil. 2004 Apr; 16(2):135-42.
    View PubMed
  318. Camilleri M. Nonmalignant gastrointestinal syndromes in the elderly: part II -- midgut and hindgut diseases. Clinical Geriatrics. 2004 Mar; 12(3):24, 25-7, 31-2.
    View PubMed
  319. Camilleri M. Chronic diarrhea: a review on pathophysiology and management for the clinical gastroenterologist. Clinical Gastroenterology & Hepatology. 2004 Mar; 2(3):198-206.
    View PubMed
  320. Delgado-Aros S, Cremonini F, Castillo JE, Chial HJ, Burton DD, Ferber I, Camilleri M. Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology. 2004 Feb; 126(2):432-40.
    View PubMed
  321. Camilleri M. Nonmalignant gastrointestinal syndromes in the elderly: part I -- alterations in physiology and foregut diseases. Clinical Geriatrics. 2004 Feb; 12(2):38-40, 41-3.
    View PubMed
  322. Delgado-Aros S, Camilleri M. [Clinical management of acute colonic pseudo-obstruction in patients: a systematic review of the literature]. [Review] [107 refs] [Spanish]. Gastroenterol Hepatol. 2003 Dec; 26(10):646-55.
    View PubMed
  323. Foxx-Orenstein A, Camilleri M, Stephens D, Burton D. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut. 2003 Nov; 52(11):1555-61.
    View PubMed
  324. Chitkara DK, Delgado-Aros S, Bredenoord AJ, Cremonini F, El-Youssef M, Freese D, Camilleri M. Functional dyspepsia, upper gastrointestinal symptoms, and transit in children. J Pediatr. 2003 Nov; 143(5):609-13.
    View PubMed
  325. Camilleri M. GI clinical research 2002-2003: the year in review. Clin Gastroenterol Hepatol. 2003 Nov; 1(6):415-20.
    View PubMed
  326. Lembo A, Camilleri M. Current concepts: Chronic constipation. N Engl J Med. 2003 Oct 2; 349(14):1360-8.
    View PubMed
  327. Delgado-Aros S, Chial HJ, Cremonini F, Ferber I, McKinzie S, Burton DD, Camilleri M. Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health. Aliment Pharmacol Ther. 2003 Sep 1; 18(5):507-14.
    View PubMed
  328. Cremonini F, Di Caro S, Delgado-Aros S, Sepulveda A, Gasbarrini G, Gasbarrini A, Camilleri M. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. 2003 Aug 1; 18(3):279-89.
    View PubMed
  329. Delgado-Aros S, Vella A, Camilleri M, Low PA, Burton DD, Thomforde GM, Stephens D. Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction. Neurogastroenterol Motil. 2003 Aug; 15(4):435-43.
    View PubMed
  330. Zangeneh F, Basu R, Shah P, Arora P, Camilleri M, Rizza RA. Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia. Am J Physiol Endocrinol Metab. 2003 Aug; 285(2):E280-6.
    View PubMed
  331. Delgado-Aros S, Cremonini F, Bredenoord AJ, Camilleri M. Systematic review and meta-analysis: does gall-bladder ejection fraction on cholecystokinin cholescintigraphy predict outcome after cholecystectomy in suspected functional biliary pain? Aliment Pharmacol Ther. 2003 Jul 15; 18(2):167-74.
    View PubMed
  332. Bredenoord AJ, Chial HJ, Camilleri M, Mullan BP, Murray JA. Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol. 2003 Jul; 1(4):264-72.
    View PubMed
  333. Delgado-Aros S, Camilleri M. Pseudo-obstruction in the critically ill. Best Practice & Research in Clinical Gastroenterology. 2003 Jun; 17(3):427-44.
    View PubMed
  334. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003 Jun; 98(6):1309-14.
    View PubMed
  335. Chial HJ, Camilleri M, Ferber I, Delgado-Aros S, Burton D, McKinzie S, Zinsmeister AR. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Clin Gastroenterol Hepatol. 2003 May; 1(3):211-8.
    View PubMed
  336. Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 2003 Apr 1; 17(7):895-904.
    View PubMed
  337. Delgado-Aros S, Chial HJ, Camilleri M, Szarka LA, Weber FT, Jacob J, Ferber I, McKinzie S, Burton DD, Zinsmeister AR. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol Gastrointest Liver Physiol. 2003 Apr; 284(4):G558-66.
    View PubMed
  338. Camilleri M, Kim DY, McKinzie S, Kim HJ, Thomforde GM, Burton DD, Low PA, Zinsmeister AR. A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2003 Mar; 1(2):111-21.
    View PubMed
  339. Camilleri M. Diagnosis and treatment of enteric neuromuscular diseases. Clin Auton Res. 2003 Feb; 13(1):10-5.
    View PubMed
  340. Cremonini F, Delgado-Aros S, Camilleri M. Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil. 2003 Feb; 15(1):79-86.
    View PubMed
  341. Chial HJ, Camilleri M, Williams DE, Litzinger K, Perrault J. Rumination syndrome in children and adolescents: diagnosis, treatment, and prognosis. Pediatrics. 2003 Jan; 111(1):158-62.
    View PubMed
  342. Chial HJ, Camilleri M, Burton D, Thomforde G, Olden KW, Stephens D. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol. 2003 Jan; 284(1):G130-7.
    View PubMed
  343. Camilleri M. Drugs targeting functional bowel disorders: lessons from drug trials. Current Opinion in Pharmacology. 2002 Dec; 2(6):684-90.
    View PubMed
  344. Bouras EP, Delgado-Aros S, Camilleri M, Castillo EJ, Burton DD, Thomforde GM, Chial HJ. SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography. Gut. 2002 Dec; 51(6):781-6.
    View PubMed
  345. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002 Dec; 123(6):2108-31.
    View PubMed
  346. Cremonini F, Mullan BP, Camilleri M, Burton DD, Rank MR. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Alimentary Pharmacology & Therapeutics. 2002 Oct; 16(10):1781-90.
    View PubMed
  347. Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE, McKinzie S, Urrutia R. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2002 Aug; 123(2):425-32.
    View PubMed
  348. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. Am J Physiol Endocrinol Metab. 2002 Aug; 283(2):E259-66.
    View PubMed
  349. Camilleri M, Heading RC, Thompson WG. Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther. 2002 Aug; 16(8):1407-30.
    View PubMed
  350. Camilleri M. Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls. Gut. 2002 Jul; 51 Suppl 1:i34-40.
    View PubMed
  351. Camilleri M. Serotonergic modulation of visceral sensation: lower gut. Gut. 2002 Jul; 51 Suppl 1:i81-6.
    View PubMed
  352. Chial HJ, Camilleri C, Delgado-Aros S, Burton D, Thomforde G, Ferber I, Camilleri M. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health. Neurogastroenterol Motil. 2002 Jun; 14(3):249-53.
    View PubMed
  353. Chial HJ, Camilleri M. Gender differences in irritable bowel syndrome. J Gend Specif Med. 2002 May-Jun; 5(3):37-45.
    View PubMed
  354. Vella A, Lee JS, Camilleri M, Szarka LA, Burton DD, Zinsmeister AR, Rizza RA, Klein PD. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Motil. 2002 Apr; 14(2):123-31.
    View PubMed
  355. Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH, Vella A, Camilleri M. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol. 2002 Mar; 282(3):G424-31.
    View PubMed
  356. Chial HJ, McAlpine DE, Camilleri M. Anorexia nervosa: Manifestations and management for the gastroenterologist. Am J Gastroenterol. 2002 Feb; 97(2):255-69.
    View PubMed
  357. Kuo B, Camilleri M, Burton D, Viramontes B, McKinzie S, Thomforde G, O'Connor MK, Brinkmann BH. Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans. Aliment Pharmacol Ther. 2002 Feb; 16(2):225-33.
    View PubMed
  358. Camilleri M. Advances in diabetic gastroparesis. Reviews in Gastroenterological Disorders. 2002; 2(2):47-56.
    View PubMed
  359. Pardi DS, Loftus EV, Camilleri M. Treatment of inflammatory bowel disease in the elderly - An update. Drugs & Aging. 2002; 19(5):355-63.
    View PubMed
  360. Liau SS, Camilleri M, Kim DY, Stephens D, Burton DD, O'Connor MK. Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging. Neurogastroenterol Motil. 2001 Dec; 13(6):533-42.
    View PubMed
  361. Viramontes BE, Kim DY, Camilleri M, Lee JS, Stephens D, Burton DD, Thomforde GM, Klein PD, Zinsmeister AR. Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil. 2001 Dec; 13(6):567-74.
    View PubMed
  362. Viramontes BE, Malcolm A, Camilleri M, Szarka LA, McKinzie S, Burton DD, Zinsmeister AR. Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol Gastrointest Liver Physiol. 2001 Dec; 281(6):G1468-76.
    View PubMed
  363. Kim DY, Delgado-Aros S, Camilleri M, Samsom M, Murray JA, O'Connor MK, Brinkmann BH, Stephens DA, Lighvani SS, Burton DD. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol. 2001 Nov; 96(11):3099-105.
    View PubMed
  364. Kim DY, Camilleri M, Murray JA, Stephens DA, Levine JA, Burton DD. Is there a role for gastric accommodation and satiety in asymptomatic obese people? Obes Res. 2001 Nov; 9(11):655-61.
    View PubMed
  365. Camilleri M, Kim DY. What is the relevance of a systematic review of pharmacological management in irritable bowel syndrome to older people? Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. J Am Geriatr Soc. 2001 Sep; 49(9):1249-52.
    View PubMed
  366. Viramontes BE, Camilleri M, McKinzie S, Pardi DS, Burton D, Thomforde GM. Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2001 Sep; 96(9):2671-6.
    View PubMed
  367. Camilleri M. Enteric nervous system disorders: genetic and molecular insights for the neurogastroenterologist. Neurogastroenterol Motil. 2001 Aug; 13(4):277-95.
    View PubMed
  368. Camilleri M, Chey WY, Mayer EA, Northcutt AR, Heath A, Dukes GE, McSorley D, Mangel AM. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med. 2001 Jul 23; 161(14):1733-40.
    View PubMed
  369. Burns TM, Lawn ND, Low PA, Camilleri M, Wijdicks EF. Adynamic ileus in severe Guillain-Barre syndrome. Muscle Nerve. 2001 Jul; 24(7):963-5.
    View PubMed
  370. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Diabetologia. 2001 Jun; 44(6):729-37.
    View PubMed
  371. Camilleri M. Pathophysiology in irritable bowel syndrome. Drug News Perspect. 2001 Jun; 14(5):268-78.
    View PubMed
  372. Bharucha AE, Camilleri M. Functional abdominal pain in the elderly. Gastroenterol Clin North Am. 2001 Jun; 30(2):517-29.
    View PubMed
  373. Coulie B, Camilleri M, Bharucha AE, Sandborn WJ, Burton D. Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine and colonic motility in patients and healthy subjects. Aliment Pharmacol Ther. 2001 May; 15(5):653-63.
    View PubMed
  374. Nehra V, Camilleri M, Burton D, Oenning L, Kelly DG. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol. 2001 May; 96(5):1494-8.
    View PubMed
  375. Aros SD, Camilleri M. Small-bowel motility. Curr Opin Gastroenterol. 2001 Mar; 17(2):140-146.
    View PubMed
  376. Camilleri M. Review article: tegaserod. Aliment Pharmacol Ther. 2001 Mar; 15(3):277-89.
    View PubMed
  377. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Diabetes. 2001 Mar; 50(3):565-72.
    View PubMed
  378. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology. 2001 Feb; 120(3):652-68.
    View PubMed
  379. Lee HR, Lennon VA, Camilleri M, Prather CM. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol. 2001 Feb; 96(2):373-9.
    View PubMed
  380. Bouras EP, Camilleri M, Burton DD, Thomforde G, McKinzie S, Zinsmeister AR. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology. 2001 Feb; 120(2):354-60.
    View PubMed
  381. Camilleri M, Coulie B, Tack JF. Visceral hypersensitivity: facts, speculations, and challenges. Gut. 2001 Jan; 48(1):125-31.
    View PubMed
  382. Camilleri M. Novel medications for the irritable bowel syndrome: motility and sensation. J Pediatr Gastroenterol Nutr. 2001; 32 Suppl 1:S35-7.
    View PubMed
  383. Camilleri M, Lee JS, Viramontes B, Bharucha AE, Tangalos EG. Progress in Geriatrics: Insights into the pathophysiology and mechanisms of constipation, IBS, and diverticulosis in the elderly. Am J Geriatr Soc. 2001.
  384. Camilleri M. Dyspepsia, irritable bowel syndrome, and constipation: review and what's new. Rev Gastroenterol Disord. 2001; 1(1):2-17.
    View PubMed
  385. Kim DY, Myung SJ, Camilleri M. Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice. Am J Gastroenterol. 2000 Dec; 95(12):3365-73.
    View PubMed
  386. Camilleri M. Neurogastroenterology: evolving concepts and techniques to study motility and hypersensitivity. Digestive & Liver Disease. 2000 Dec; 32(Suppl 3):S227-32.
    View PubMed
  387. Camilleri M. Functional bowel disease: roles of sensation and motility. Schweiz Med Wochenschr. 2000 Nov 18; 130(46):1772-81.
    View PubMed
  388. Bharucha AE, Camilleri M, Haydock S, Ferber I, Burton D, Cooper S, Tompson D, Fitzpatrick K, Higgins R, Zinsmeister AR. Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut. 2000 Nov; 47(5):667-74.
    View PubMed
  389. Maleki D, Locke GR 3rd, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, Melton LJ 3rd. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000 Oct 9; 160(18):2808-16.
    View PubMed
  390. Coulie B, Camilleri M. New therapies for functional bowel diseases. Curr Gastroenterol Rep. 2000 Oct; 2(5):355-63.
    View PubMed
  391. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol. 2000 Oct; 95(10):2698-709.
    View PubMed
  392. Lee JS, Camilleri M, Zinsmeister AR, Burton DD, Choi MG, Nair KS, Verlinden M. Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test. Am J Gastroenterol. 2000 Oct; 95(10):2751-61.
    View PubMed
  393. Camilleri M, Lee JS, Viramontes B, Bharucha AE, Tangalos EG. Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people. J Am Geriatr Soc. 2000 Sep; 48(9):1142-50.
    View PubMed
  394. Thumshirn M, Coulie B, Camilleri M, Zinsmeister AR, Burton DD, Van Dyke C. Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2000 Jul; 14(7):869-78.
    View PubMed
  395. Coulie B, Szarka LA, Camilleri M, Burton DD, McKinzie S, Stambler N, Cedarbaum JM. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology. 2000 Jul; 119(1):41-50.
    View PubMed
  396. Nehra V, Bruce BK, Rath-Harvey DM, Pemberton JH, Camilleri M. Psychological disorders in patients with evacuation disorders and constipation in a tertiary practice. Am J Gastroenterol. 2000 Jul; 95(7):1755-8.
    View PubMed
  397. Lee JS, Camilleri M, Zinsmeister AR, Burton DD, Kost LJ, Klein PD. A valid, accurate, office based non-radioactive test for gastric emptying of solids. Gut. 2000 Jun; 46(6):768-73.
    View PubMed
  398. Malcolm A, Camilleri M, Kost L, Burton DD, Fett SL, Zinsmeister AR. Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function. Aliment Pharmacol Ther. 2000 Jun; 14(6):783-93.
    View PubMed
  399. Samsom M, Szarka LA, Camilleri M, Vella A, Zinsmeister AR, Rizza RA. Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol Gastrointest Liver Physiol. 2000 Jun; 278(6):G946-51.
    View PubMed
  400. Camilleri M, Williams DE. Economic burden of irritable bowel syndrome - proposed strategies to control expenditures. Pharmacoeconomics. 2000 Apr; 17(4):331-338.
    View PubMed
  401. Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet. 2000 Mar 25; 355(9209):1035-40.
    View PubMed
  402. Malcolm A, Camilleri M. Coloanal motor coordination in association with high-amplitude colonic contractions after pharmacological stimulation. Am J Gastroenterol. 2000 Mar; 95(3):715-9.
    View PubMed
  403. Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology. 2000 Mar; 118(3):463-8.
    View PubMed
  404. Camilleri M. Pharmacology and clinical experience with alosetron. Expert Opin Investig Drugs. 2000 Jan; 9(1):147-59.
    View PubMed
  405. Lee JS, Camilleri M. Image of the month. Gastroenterology. 2000; 119:614.
  406. Camilleri M. Ten secrets for development of drugs for functional gastrointestinal diseases. Comments from the Editors Gastroenterology. 2000; 118:653.
  407. Kellow JE, Delvaux MM, Azpiroz F, Camilleri M, Quigley EMM, Thompson DG. Principles of applied neurogastroenterology: motility/sensation - sensation Rome II: The Functional Gastrointestinal Disorders, 2nd ed. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Lawrence, KS: Allen Press, Inc., 2000, pp. 91-156 2000.
  408. Kuiken SD, Samsom M, Camilleri M, Mullan BP, Burton DD, Kost LJ, Hardyman TJ, Brinkmann BH, O'Connor MK. Development of a test to measure gastric accommodation in humans. Am J Physiol. 1999 Dec; 277(6 Pt 1):G1217-21.
    View PubMed
  409. Camilleri M. Clinical subgroups of chronic constipation: exploring the potential of polyethylene glycol. Italian Journal of Gastroenterology & Hepatology. 1999 Nov; 31(Suppl 3):S253-4.
  410. Camilleri M, Calobrisi SD. Skin eruptions in the diaper area. Curr Probl Dermatol. 1999 Nov-Dec; 11(6):213-244.
  411. Camilleri M, Mayer EA, Drossman DA, Heath A, Dukes GE, McSorley D, Kong S, Mangel AW, Northcutt AR. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther. 1999 Sep; 13(9):1149-59.
    View PubMed
  412. Bouras EP, O'Brien TJ, Camilleri M, O'Connor MK, Mullan BP. Cerebral topography of rectal stimulation using single photon emission computed tomography. Am J Physiol. 1999 Sep; 277(3 Pt 1):G687-94.
    View PubMed
  413. Kellow JE, Delvaux M, Azpiroz F, Camilleri M, Quigley EMM, Thompson DG. Principles of applied neurogastroenterology: physiology/motility-sensation. Gut. 1999 Sep; 45(Suppl 2):17-24.
    View PubMed
  414. Bouras EP, Camilleri M, Burton DD, McKinzie S. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut. 1999 May; 44(5):682-6.
    View PubMed
  415. Camilleri M. Review article: clinical evidence to support current therapies of irritable bowel syndrome. Aliment Pharmacol Ther. 1999 May; 13 Suppl 2:48-53.
    View PubMed
  416. Mueller LA, Camilleri M, Emslie-Smith AM. Mitochondrial neurogastrointestinal encephalomyopathy: manometric and diagnostic features. Gastroenterology. 1999 Apr; 116(4):959-63.
    View PubMed
  417. Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR. Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology. 1999 Mar; 116(3):573-85.
    View PubMed
  418. Mollen RM, Salvioli B, Camilleri M, Burton D, Kost LJ, Phillips SF, Pemberton JH. The effects of biofeedback on rectal sensation and distal colonic motility in patients with disorders of rectal evacuation: evidence of an inhibitory rectocolonic reflex in humans? Am J Gastroenterol. 1999 Mar; 94(3):751-6.
    View PubMed
  419. Camilleri M. Motor function in irritable bowel syndrome. Can J Gastroenterol. 1999 Mar; 13 Suppl A:8A-11A.
    View PubMed
  420. Scolapio JS, Camilleri M, Weckwerth JA, Romano M. Audit of the treatment of malnutrition due to chronic intestinal pseudo-obstruction with enteral nutrition. Nutr Clin Pract. 1999 Feb; 14(1):29-32.
  421. Harewood GC, Coulie B, Camilleri M, Rath-Harvey D, Pemberton JH. Descending perineum syndrome: audit of clinical and laboratory features and outcome of pelvic floor retraining. Am J Gastroenterol. 1999 Jan; 94(1):126-30.
    View PubMed
  422. Thumshirn M, Camilleri M, Saslow SB, Williams DE, Burton DD, Hanson RB. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut. 1999 Jan; 44(1):55-64.
    View PubMed
  423. Forstner-Barthell AW, Murr MM, Nitecki S, Camilleri M, Prather CM, Kelly KA, Sarr MG. Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients. J Gastrointest Surg. 1999 Jan-Feb; 3(1):15-21, discussion 21-3.
    View PubMed
  424. Camilleri M. Chronic intestinal pseudo-obstruction Approach to the Patient with Chronic Gastrointestinal Disorders. Corazziari E, ed. Millan: Messaggi srl, 1999:pp. 271-93.
  425. Camilleri M. Review article: Functional bowel disease: a challenging frontier in gastroenterology. Maltese Medical Journal. 1999; 11:4-14.
  426. Camilleri M. Therapeutic approach to the patient with irritable bowel syndrome. Am J Med. 1999; 107(5 Suppl 1):27-32.
    View PubMed
  427. Coulie B, Camilleri M. Intestinal pseudo-obstruction. Annu Rev Med. 1999; 50:37-55.
    View PubMed
  428. Wagaman JR, Williams DE, Camilleri M. Behavioral intervention for the treatment of rumination. J Pediatr Gastroenterol Nutr. 1998 Nov; 27(5):596-8.
    View PubMed
  429. Maleki D, Camilleri M, Burton DD, Rath-Harvey DM, Oenning L, Pemberton JH, Low PA. Pilot study of pathophysiology of constipation among community diabetics. Dig Dis Sci. 1998 Nov; 43(11):2373-8.
    View PubMed
  430. Camilleri M, Hasler WL, Parkman HP, Quigley EM, Soffer E. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology. 1998 Sep; 115(3):747-62.
    View PubMed
  431. Thumshirn M, Camilleri M, Hanson RB, Williams DE, Schei AJ, Kammer PP. Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol Gastrointest Liver Physiol. 1998 Aug; 275(2):G 314-G 321.
  432. Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol. 1998 Jul; 93(7):1085-9.
    View PubMed
  433. Saslow SB, Scolapio JS, Camilleri M, Forstrom LA, Thomforde GM, Burton DD, Rubin J, Pitot HC, Zinsmeister AR. Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea. Gut. 1998 May; 42(5):628-34.
    View PubMed
  434. Choi MG, Camilleri M, Burton DD, Johnson S, Edmonds A. Dose-related effects of N-demethyl-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal on gastric emptying of solids in healthy human volunteers. J Pharmacol Exp Ther. 1998 Apr; 285(1):37-40.
    View PubMed
  435. Camilleri M, Ford MJ. Review article: colonic sensorimotor physiology in health, and its alteration in constipation and diarrhoeal disorders. Alimentary Pharmacology & Therapeutics. 1998 Apr; 12(4):287-302.
    View PubMed
  436. Hammer HF, Phillips SF, Camilleri M, Hanson RB. Rectal tone, distensibility, and perception - reproducibility and response to different distensions. Am J Physiol Gastrointest Liver Physiol. 1998 Mar; 274(3):G 584-G 590.
  437. Mullan BP, Camilleri M, Hung JC. Activated charcoal as a potential radioactive marker for gastrointestinal studies. Nucl Med Commun. 1998 Mar; 19(3):237-40.
    View PubMed
  438. Saslow SB, Thumshirn M, Camilleri M, Locke GR 3rd, Thomforde GM, Burton DD, Hanson RB. Influence of H. pylori infection on gastric motor and sensory function in asymptomatic volunteers. Dig Dis Sci. 1998 Feb; 43(2):258-64.
    View PubMed
  439. Farrugia G, Nitecki S, Harty GJ, Camilleri M, Szurszewski JH. The effect of flufenamic acid on gastrointestinal myoelectrical activity and transit time in dogs. Gut. 1998 Feb; 42(2):258-65.
    View PubMed
  440. Frank JW, Camilleri M, Thomforde GM, Dinneen SF, Rizza RA. Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans. Metabolism. 1998 Jan; 47(1):7-12.
    View PubMed
  441. Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA, Nair KS. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol. 1998 Jan; 93(1):92-8.
    View PubMed
  442. Camilleri M. Gastric emptying in diabetes mellitus: potential strategies to achieve euglycemia. Motility. 1998; issue 43:4-6.
  443. Camilleri M. Gastrointestinal motility disorders. Scientific American Medicine. Dale DC, Federman DD, eds. New York: Scientific American Medicine Publishers, 1998.
  444. Camilleri M, Maleki D, Barnett D. Gastrointestinal complications of diabetes mellitus. The Uncomplicated Guide to Diabetes Complications. Levin ME, Pfeiffer MA, eds. Alexandria, VA: American Diabetes Association, 1998:pp. 236-49.
  445. Camilleri M. Motor function in functional dyspepsia and irritable bowel syndrome. Functional Dyspepsia and Irritable bowel syndrome: Concepts and Controversies. Goebell H, Holtmann G, Talley N, eds. Lancaster, U.K.: Kluwer Academic Publishers, 1998:pp 103-12.
  446. Fujimura J, Camilleri M, Low PA, Novak V, Novak P, Opfer-Gehrking TL. Effect of perturbations and a meal on superior mesenteric artery flow in patients with orthostatic hypotension. J Auton Nerv Syst. 1997 Dec 3; 67(1-2):15-23.
    View PubMed
  447. Saslow SB, O'Brien MD, Camilleri M, von der Ohe M, Homburger HA, Klee GG, Pitot HC, Rubin J. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome. Am J Gastroenterol. 1997 Dec; 92(12):2250-6.
    View PubMed
  448. Burton DD, Camilleri M, Mullan BP, Forstrom LA, Hung JC. Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med. 1997 Nov; 38(11):1807-10.
    View PubMed
  449. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol. 1997 Nov; 273(5 Pt 1):G997-1006.
    View PubMed
  450. Bharucha AE, Novak V, Camilleri M, Zinsmeister AR, Hanson RB, Low PA. Alpha 2-adrenergic modulation of colonic tone during hyperventilation. Am J Physiol. 1997 Nov; 273(5 Pt 1):G1135-40.
    View PubMed
  451. Malcolm A, Phillips SF, Camilleri M, Hanson RB. Pharmacological modulation of rectal tone alters perception of distention in humans. Am J Gastroenterol. 1997 Nov; 92(11):2073-9.
    View PubMed
  452. Scolapio JS, Camilleri M, Fleming CR, Oenning LV, Burton DD, Sebo TJ, Batts KP, Kelly DG. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology. 1997 Oct; 113(4):1074-81.
    View PubMed
  453. Maleki D, Camilleri M, Zinsmeister AR, Rizza RA. Effect of acute hyperglycemia on colorectal motor and sensory function in humans. Am J Physiol Gastrointest Liver Physiol. 1997 Oct; 273(4):G 859-G 864.
  454. Thumshirn M, Bruninga K, Camilleri M. Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis. Am J Gastroenterol. 1997 Sep; 92(9):1496-500.
    View PubMed
  455. Malcolm A, Thumshirn MB, Camilleri M, Williams DE. Rumination syndrome. Mayo Clin Proc. 1997 Jul; 72(7):646-52.
    View PubMed
  456. Scolapio JS, Camilleri M, Fleming CR. Gastrointestinal motility considerations in patients with short-bowel syndrome. Dig Dis. 1997 Jul-Oct; 15(4-5):253-62.
    View PubMed
  457. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997 Jun; 112(6):2120-37.
    View PubMed
  458. Bruninga K, Camilleri M. Colonic motility and tone after spinal cord and cauda equina injury. Am J Gastroenterol. 1997 May; 92(5):891-4.
    View PubMed
  459. Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA, Nair KS. [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology. 1997 Apr; 112(4):1155-62.
    View PubMed
  460. Charles F, Phillips SF, Camilleri M, Thomforde GM. Rapid gastric emptying in patients with functional diarrhea. Mayo Clin Proc. 1997 Apr; 72(4):323-8.
    View PubMed
  461. Nguyen A, Camilleri M, Kost LJ, Metzger A, Sarr MG, Hanson RB, Fett SL, Zinsmeister AR. SDZ HTF 919 stimulates canine colonic motility and transit in vivo. J Pharmacol Exp Ther. 1997 Mar; 280(3):1270-6.
    View PubMed
  462. Camilleri M, Choi MG. Irritable bowel syndrome. Aliment Pharmacol Ther. 1997 Feb; 11(1):3-15.
    View PubMed
  463. Choi MG, Camilleri M, O'Brien MD, Kammer PP, Hanson RB. A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia. Am J Gastroenterol. 1997 Feb; 92(2):297-302.
    View PubMed
  464. Loftus EV Jr, Farrugia G, Donohue JH, Camilleri M. Duodenal obstruction: diagnosis by gastroduodenal manometry. Mayo Clin Proc. 1997 Feb; 72(2):130-2.
    View PubMed
  465. O'Brien MD, Camilleri M, Thomforde GM, Wiste JA, Hanson RB, Zinsmeister AR. Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit. Dig Dis Sci. 1997 Jan; 42(1):26-33.
    View PubMed
  466. Camilleri M. Diarrhea and irritable bowel syndrome: Practical approaches. Surgery and Colon & Rectum. Nicholls RJ, Dozois RR, eds. London: Churchill Livingstone, 1997:pp. 681-689.
  467. Camilleri M. Dysautonomic findings in functional gastrointestinal disorders. Functional Dyspepsia. Mearin F, ed. Barcelona, Spain: Doyma Publishers, 1997:pp. 133-138.
  468. Whitehead WE, Delvaux M, Azpiroz F, Barlow J, Bradley L, Camilleri M, Crowell MD, Enck P, Fioramonti J, Janssens J, Mayer EA, Morteau O, Phillips SF, Thompson DG, Wingate DL. Standardization of procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. Dig Dis Sci. 1997; 42:223-41.
    View PubMed
  469. O'Brien MD, Camilleri M, von der Ohe MR, Phillips SF, Pemberton JH, Prather CM, Wiste JA, Hanson RB. Motility and tone of the left colon in constipation: a role in clinical practice? Am J Gastroenterol. 1996 Dec; 91(12):2532-8.
    View PubMed
  470. Camilleri M, Bharucha AE. Gastrointestinal dysfunction in neurologic disease. Semin Neurol. 1996 Sep; 16(3):203-16.
    View PubMed
  471. Bharucha AE, Camilleri M, Ford MJ, O'Connor MK, Hanson RB, Thomforde GM. Hyperventilation alters colonic motor and sensory function: effects and mechanisms in humans. Gastroenterology. 1996 Aug; 111(2):368-77.
    View PubMed
  472. Ford MJ, Camilleri M, Joyner MJ, Hanson RB. Autonomic control of colonic tone and the cold pressore test. Gut. 1996 Jul; 39(1):125-9.
    View PubMed
  473. Camilleri M, Balm RK, Zinsmeister AR. Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility. Aliment Pharmacol Ther. 1996 Jun; 10(3):403-9.
    View PubMed
  474. Camilleri M. Gastrointestinal problems in diabetes. Endocrinology & Metabolism Clinics of North America. 1996 Jun; 25(2):361-78.
    View PubMed
  475. Camilleri M. Nonulcer dyspepsia: a look into the future. Mayo Clin Proc. 1996 Jun; 71(6):614-22.
    View PubMed
  476. Zein NN, Perrault J, Camilleri M. Recurrent vomiting following Harrington rod instrumentation of the spine. Journal of Pediatric Gastroenterology & Nutrition. 1996 Apr; 22(3):318-20.
    View PubMed
  477. Surrenti E, Camilleri M, Kammer PP, Prather CM, Schei AJ, Hanson RB. Antral axial forces postprandially and after erythromycin in organic and functional dysmotilities. Dig Dis Sci. 1996 Apr; 41(4):697-704.
    View PubMed
  478. Farrugia G, Camilleri M, Whitehead WE. Therapeutic strategies for motility disorders. Medications, nutrition, biofeedback, and hypnotherapy. Gastroenterol Clin North Am. 1996 Mar; 25(1):225-46.
    View PubMed
  479. Camilleri M, Saslow SB, Bharucha AE. Gastrointestinal sensation. Mechanisms and relation to functional gastrointestinal disorders. Gastroenterol Clin North Am. 1996 Mar; 25(1):247-58.
    View PubMed
  480. Scolapio JS, Camilleri M. Nonulcer dyspepsia. Gastroenterologist. 1996 Mar; 4(1):13-23.
    View PubMed
  481. Saslow SB, Camilleri M, Thomforde GM, Van Dyke CT, Pitot HC, Rubin J. Relation between fat malabsorption and transit abnormalities in human carcinoid diarrhea. Gastroenterology. 1996 Feb; 110(2):405-10.
    View PubMed
  482. Camilleri M. Effect of altered control of the autonomic nervous system on gastrointestinal function. Proceedings of the International Symposium of NeuroGastroenterology. Corazziari E, ed. Berlin: Walter De Gruyter & Co., 1996:pp. 187-198.
  483. Camilleri M, Saslow SB. Somatostatin analogs in the treatment of gastrointestinal motility disorders Advances in Gastroenterology Hepatology & Clinical Nutrition , 1996; 1:291-8.
  484. Camilleri M. Gastrointestinal neuropathies relieved by prokinetic therapy Gastroenterology Observer. 1996; 15:2-3.
  485. Camilleri M. Effects of somatostatin analogues on human gastrointestinal motility. Digestion. 1996; 57 Suppl 1:90-2.
    View PubMed
  486. Talley NJ, Camilleri M. Epidemiological features of functional dyspepsia and irritable bowel syndrome. Clinican. 1996; 14:7-13.
  487. Ford MJ, Camilleri M, Zinsmeister AR, Hanson RB. Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology. 1995 Dec; 109(6):1772-80.
    View PubMed
  488. Murr MM, Sarr MG, Camilleri M. The surgeon's role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol. 1995 Dec; 90(12):2147-51.
    View PubMed
  489. Ford MJ, Camilleri MJ, Hanson RB, Wiste JA, Joyner MJ. Hyperventilation, central autonomic control, and colonic tone in humans. Gut. 1995 Oct; 37(4):499-504.
    View PubMed
  490. Rowe FA, Camilleri M, Forstrom LA, Batts KP, Mullan BP, Thomforde GM, Dunn W, Zinsmeister AR. A pilot study of splenic and whole body retention of autologous radiolabeled leukocytes in the assessment of severity in inflammatory colitis. Am J Gastroenterol. 1995 Oct; 90(10):1771-5.
    View PubMed
  491. Saslow SB, Camilleri M. Diabetic diarrhea. Semin Gastrointest Dis. 1995 Oct; 6(4):187-93.
    View PubMed
  492. Frank JW, Saslow SB, Camilleri M, Thomforde GM, Dinneen S, Rizza RA. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology. 1995 Sep; 109(3):755-65.
    View PubMed
  493. Surrenti E, Rath DM, Pemberton JH, Camilleri M. Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol. 1995 Sep; 90(9):1471-5.
    View PubMed
  494. Ford MJ, Camilleri M, Wiste JA, Hanson RB. Differences in colonic tone and phasic response to a meal in the transverse and sigmoid human colon. Gut. 1995 Aug; 37(2):264-9.
    View PubMed
  495. Camilleri M. Gastrointestinal manifestations of diabetes mellitus. (Overview). Eur J Gastroenterol Hepatol. 1995 Aug; 7:709-710.
  496. Singaram C, Sweet MA, Gaumnitz EA, Cameron AJ, Camilleri M. Peptidergic and nitringergic denervation in congenital esophageal stenosis. (Note). Gastroenterology. 1995 Jul; 109:275-281.
    View PubMed
  497. Scolapio JS, Camilleri M, von der Ohe MR, Hanson RB. Ascending colon response to feeding: evidence for a 5-hydroxytryptamine-3 mechanism. Scand J Gastroenterol. 1995 Jun; 30(6):562-7.
    View PubMed
  498. von der Ohe MR, Camilleri M, Thomforde GM, Klee GG. Differential regional effects of octreotide on human gastrointestinal motor function. Gut. 1995 May; 36(5):743-8.
    View PubMed
  499. Forstrom LA, Dunn WL, Rowe FA, Camilleri M. 111In-oxine-labelled granulocyte dosimetry in normal subjects. Nucl Med Commun. 1995 May; 16(5):349-56.
    View PubMed
  500. Gaspari JC, Sande JR, Thomas CF Jr, Zighelboim J, Camilleri M. Lupus anticoagulant masquerading as an acute abdomen with multiorgan involvement. Am J Gastroenterol. 1995 May; 90(5):825-6.
    View PubMed
  501. Pemberton JH, Camilleri M, Fleshman JW. Clinical management of the constipated patient. Ann Intern Med. 1995 Apr 15; 122:632.
  502. O'Brien MD, Bruce BK, Camilleri M. The rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology. 1995 Apr; 108(4):1024-9.
    View PubMed
  503. Charles F, Camilleri M, Phillips SF, Thomforde GM, Forstrom LA. Scintigraphy of the whole gut: clinical evaluation of transit disorders. Mayo Clin Proc. 1995 Feb; 70(2):113-8.
    View PubMed
  504. Thomforde GM, Camilleri M, Phillips SF, Forstrom LA. Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med. 1995 Jan; 36(1):93-6.
    View PubMed
  505. Camilleri M. The management of chronic intestinal psuedo-obstruction Motility. 1995; 30:7-10.
  506. Camilleri M. Irritable bowel syndrome: the pathophysiologic links to more effective future therapy Participate Practical Gastroenterology (reprint), 1316-18, 1999 1995; 4:1-2.
  507. Camilleri M, Ford M, Bharucha A, Hanson R, Zinsmeister A. Psychosensory and autonomic modulation of colonic sensation in healthy humans. Third International Symposium on Brain-Gut Interactions Cambridge, UK, July 19-22, 1995.
  508. Low PA, Opfer-Gehrking TL, Textor SC, Schondorf R, Suarez GA, Fealey RD, Camilleri M. Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure. J Auton Nerv Syst. 1994 Dec 15; 50(2):181-8.
    View PubMed
  509. Camilleri M, Prather CM. Axial forces during gastric emptying in health and models of disease. Dig Dis Sci. 1994 Dec; 39(12 Suppl):14S-17S.
    View PubMed
  510. Camilleri M, Thompson WG, Fleshman JW, Pemberton JH. Clinical management of intractable constipation. Ann Intern Med. 1994 Oct 1; 121(7):520-8.
    View PubMed
  511. Camilleri M. Appraisal of medium- and long-term treatment of gastroparesis and chronic intestinal dysmotility. Am J Gastroenterol. 1994 Oct; 89(10):1769-74.
    View PubMed
  512. von der Ohe MR, Camilleri M, Carryer PW. A patient with localized megacolon and intractable constipation: evidence for impairment of colonic muscle tone. Am J Gastroenterol. 1994 Oct; 89(10):1867-70.
    View PubMed
  513. Suarez GA, Fealey RD, Camilleri M, Low PA. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology. 1994 Sep; 44(9):1675-82.
    View PubMed
  514. Vonderohe MR, Hanson RB, Camilleri M. Comparison of simultaneous recordings of human colonic contractions by manometry and a barostat. Neurogastroenterol Motil. 1994 Sep; 6:213-222.
  515. Haruma K, Wiste JA, Camilleri M. Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders. Gut. 1994 Aug; 35(8):1064-9.
    View PubMed
  516. Camilleri M, Von der Ohe MR. Drugs affecting serotonin receptors. Baillieres Clin Gastroenterol. 1994 Jun; 8(2):301-19.
    View PubMed
  517. von der Ohe MR, Camilleri M, Kvols LK. A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology. 1994 May; 106(5):1184-9.
    View PubMed
  518. Camilleri M. Human gastroduodenojejunal manometry. Dig Dis Sci. 1994 May; 39:1149-1150.
  519. Camilleri M, Balm RK, Zinsmeister AR. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. Gastroenterology. 1994 Apr; 106(4):916-23.
    View PubMed
  520. von der Ohe MR, Hanson RB, Camilleri M. Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. Gut. 1994 Apr; 35(4):536-41.
    View PubMed
  521. Camilleri M. Small bowel motility disorders. Rev Gastroenterol Mex. 1994 Apr-Jun; 59(2):120-6.
    View PubMed
  522. Frank JW, Sarr MG, Camilleri M. Use of gastroduodenal manometry to differentiate mechanical and functional intestinal obstruction: an analysis of clinical outcome. Am J Gastroenterol. 1994 Mar; 89(3):339-44.
    View PubMed
  523. Camilleri M. Atlas of Gastrointestinal Motility in Health and Disease Gastroenterology ( 1994; Book review).
  524. Valdovinos MA, Camilleri M, Thomforde GM, Frie C. Reduced accuracy of 14C-D-xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders. Scand J Gastroenterol. 1993 Nov; 28(11):963-8.
    View PubMed
  525. Von Der Ohe M, Camilleri M, Zimmerman BR. Management of diabetic enteropathy. Endocrinologist. 1993 Nov; 3:400-408.
  526. von der Ohe MR, Camilleri M, Kvols LK, Thomforde GM. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med. 1993 Oct 7; 329(15):1073-8.
    View PubMed
  527. Hammer J, Phillips SF, Talley NJ, Camilleri M. Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Aliment Pharmacol Ther. 1993 Oct; 7(5):543-51.
    View PubMed
  528. Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc. 1993 Jul; 68(7):691-702.
    View PubMed
  529. Aggarwal AM, Camilleri M, Phillips SF, Schlagheck TG, Brown ML, Thomforde GM. Olestra, a nondigestible, nonabsorbable fat. Effects on gastrointestinal and colonic transit. Dig Dis Sci. 1993 Jun; 38(6):1009-14.
    View PubMed
  530. Oosterbosch L, von der Ohe M, Valdovinos MA, Kost LJ, Phillips SF, Camilleri M. Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action. Gut. 1993 Jun; 34(6):794-8.
    View PubMed
  531. Badley AD, Camilleri M, O'Connor MK. Noninvasive measurement of human ascending colon volume. Nucl Med Commun. 1993 Jun; 14(6):485-9.
    View PubMed
  532. Prather CM, Camilleri M, Thomforde GM, Forstrom LA, Zinsmeister AR. Gastric axial forces in experimentally delayed and accelerated gastric emptying. Am J Physiol. 1993 May; 264(5 Pt 1):G928-34.
    View PubMed
  533. Camilleri M. Study of human gastroduodenojejunal motility. Dig Dis Sci. 1993 May; 38:785-794.
    View PubMed
  534. Camilleri M, Balm RK, Low PA. Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction. Clin Auton Res. 1993 Apr; 3(2):95-100.
    View PubMed
  535. Bharucha AE, Camilleri M, Low PA, Zinsmeister AR. Autonomic dysfunction in gastrointestinal motility disorders. Gut. 1993 Mar; 34(3):397-401.
    View PubMed
  536. Hammer J, Camilleri M, Phillips SF, Aggarwal A, Haddad AM. Does the ileocolonic junction differentiate between solids and liquids? Gut. 1993 Feb; 34(2):222-6.
    View PubMed
  537. Leighton JA, Valdovinos MA, Pemberton JH, Rath DM, Camilleri M. Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis. Dis Colon Rectum. 1993 Feb; 36(2):182-5.
    View PubMed
  538. Valdovinos MA, Thomforde GM, Camilleri M. Effect of putative carcinoid mediators on gastric and small bowel transit in rats and the role of 5-HT receptors. Aliment Pharmacol Ther. 1993 Feb; 7(1):61-6.
    View PubMed
  539. Camilleri M. Four patients with intractable constipation. Gastrointestinal Diseases Today. 1993; 2:7-15.
  540. von der Ohe MR, Camilleri M. Measurement of small bowel and colonic transit: indications and methods. Mayo Clin Proc. 1992 Dec; 67(12):1169-79.
    View PubMed
  541. Miedema BW, Kelly KA, Camilleri M, Hanson RB, Zinsmeister AR, O'Connor MK, Brown ML. Human gastric and jejunal transit and motility after Roux gastrojejunostomy. Gastroenterology. 1992 Oct; 103(4):1133-43.
    View PubMed
  542. Fich A, Steadman CJ, Phillips SF, Camilleri M, Brown ML, Haddad AC, Thomforde GM. Ileocolonic transit does not change after right hemicolectomy. Gastroenterology. 1992 Sep; 103(3):794-9.
    View PubMed
  543. Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc. 1992 Aug; 67(8):725-31.
    View PubMed
  544. Vassallo MJ, Camilleri M, Prather CM, Hanson RB, Thomforde GM. Measurement of axial forces during emptying from the human stomach. Am J Physiol. 1992 Aug; 263(2 Pt 1):G230-9.
    View PubMed
  545. Camilleri M, Prather CM, Evans MA, Andresen-Reid ML. Balance studies and polymeric glucose solution to optimize therapy after massive intestinal resection. Mayo Clin Proc. 1992 Aug; 67(8):755-60.
    View PubMed
  546. Camilleri M, Zinsmeister AR. Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders. Gastroenterology. 1992 Jul; 103(1):36-42.
    View PubMed
  547. Ruytjens I, Thomforde GM, Camilleri M, Chapman NJ. Effect of chemical sympathectomy on scintigraphic gastric and small bowel transit in the rat. J Auton Nerv Syst. 1992 Jun 15; 39(2):111-7.
    View PubMed
  548. Camilleri M, Prather CM. The irritable bowel syndrome: mechanisms and a practical approach to management. Ann Intern Med. 1992 Jun 15; 116(12 Pt 1):1001-8.
    View PubMed
  549. Stark ME, Camilleri M, Fitzpatrick LA, Van Heerden JA. A 47-year-old woman with chronic constipation, hypercalcemia, and pulmonary nodule. Gastroenterology. 1992 Jun; 5:115-125.
  550. Steadman CJ, Phillips SF, Camilleri M, Talley NJ, Haddad A, Hanson R. Control of muscle tone in the human colon. Gut. 1992 Apr; 33(4):541-6.
    View PubMed
  551. Vassallo MJ, Camilleri M, Sullivan SN, Thomforde GM. Effects of erythromycin on gut transit in pseudo-obstruction due to hereditary coproporphyria. J Clin Gastroenterol. 1992 Apr; 14(3):255-9.
    View PubMed
  552. Vassallo M, Camilleri M, Phillips SF, Brown ML, Chapman NJ, Thomforde GM. Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology. 1992 Jan; 102(1):102-8.
    View PubMed
  553. Prather CM, Camilleri M. Medical management of small bowel motility disorders and chronic intestinal pseudo-obstruction. Pract Gastroenterol. 1992; 16:25-37.
  554. Camilleri M. Targeting therapy for the irritable bowel syndrome. Med Actual. 1992; 28:581-589.
  555. Layer P, Camilleri M. Erbrechan Gastroenterologie Vol 10 Goebell H(ed) Innere Medizine de Gegenwart Munchen, Wien, & Schwarzenberg, , pp 87-92 1992; Baltimore:Urban.
  556. Layer P, Berges F-W, Camilleri M, Ihe M v d Erckenbrecht JF. Untersuchungen der motilitat und des transits Gastroenterologie Vol 10 Goebell H (ed) Innere Medizin der Gegenwart Munchen, Wien, & Schwarzenberg, , pp 186-203 1992; Baltimore:Urban.
  557. Steadman CJ, Phillips SF, Camilleri M, Haddad AC, Hanson RB. Variation of muscle tone in the human colon. Gastroenterology. 1991 Aug; 101(2):373-81.
    View PubMed
  558. Camilleri M, Carbone LD, Schuffler MD. Familial enteric neuropathy with pseudoobstruction. Dig Dis Sci. 1991 Aug; 36(8):1168-71.
    View PubMed
  559. Stivland T, Camilleri M, Vassallo M, Proano M, Rath D, Brown ML, Thomforde G, Pemberton JH, Phillips SF. Scintigraphic measurement of regional gut transit idiopathic constipation. Gastroenterology. 1991 Jul; 101:107-115.
    View PubMed
  560. Phillips SF, Camilleri M. The ileocecal area and the irritable bowel syndrome. Gastroenterol Clin North Am. 1991 Jun; 20(2):297-311.
    View PubMed
  561. Camilleri M, Vassallo M. Small intestinal motility and transit in disease. Baillieres Clin Gastroenterol. 1991 Jun; 5(2):431-51.
    View PubMed
  562. Camilleri M, Zinsmeister AR, Greydanus MP, Brown ML, Proano M. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci. 1991 May; 36(5):609-15.
    View PubMed
  563. Abell TL, Camilleri M, DiMagno EP, Hench VS, Zinsmeister AR, Malagelada JR. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci. 1991 May; 36(5):616-20.
    View PubMed
  564. Greydanus MP, Vassallo M, Camilleri M, Nelson DK, Hanson RB, Thomforde GM. Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology. 1991 May; 100(5 Pt 1):1311-8.
    View PubMed
  565. Abell TL, Camilleri M, Hench VS, Malagelada JR. Gastric electromechanical function and gastric emptying in diabetic gastroparesis. Eur J Gastroenterol Hepatol. 1991 Feb; 3:163-167.
  566. Vassallo M, Camilleri M, Caron BL, Low PA. Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis. Gastroenterology. 1991 Jan; 100(1):252-8.
    View PubMed
  567. Lennon VA, Sas DF, Busk MF, Scheithauer B, Malagelada JR, Camilleri M, Miller LJ. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology. 1991 Jan; 100(1):137-42.
    View PubMed
  568. Proano M, Camilleri M, Phillips SF, Thomforde GM, Brown ML, Tucker RL. Unprepared human colon does not discriminate between solids and liquids. Am J Physiol. 1991 Jan; 260(1 Pt 1):G13-6.
    View PubMed
  569. Sandborn WJ, Camilleri M. Laboratory investigation in inflammatory bowel disease. Pract Gastroenterol. 1991; 15:11-15.
  570. Camilleri M, Phillips SF. Acute and chronic intestinal pseudo-obstruction. Adv Intern Med. 1991; 36:287-306.
    View PubMed
  571. Camilleri M. Medical treatment of chronic intestinal pseudo-obstruction. Pract Gastroenterol. 1991; 15:10-22.
  572. Kim CH, Kennedy FP, Camilleri M, Zinsmeister AR, Ballard DJ. The relationship between clinical factors and gastrointestinal dysmotility in diabetes mellitus. Journal of Gastrointestinal Motility. 1991; 3:268-272.
  573. Kelly DG, Camilleri M. Gastrointestinal motility. Support Line. 1991; 13:7-10.
  574. Camilleri M. A guide to the treatment of GI motility disorders. Drug Therapy. 1991; 21:15-28.
    View PubMed
  575. Thomforde GM, Malagelada JR, Camilleri M, Yaksh TL. Demonstration of intrathecal and systemic morphine and ST-91 effects on fed canine upper gut motility. Dig Dis Sci. 1990 Oct; 35(10):1249-56.
    View PubMed
  576. Fich A, Neri M, Camilleri M, Kelly KA, Phillips SF. Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients. J Clin Gastroenterol. 1990 Oct; 12(5):505-12.
    View PubMed
  577. Greydanus MP, Camilleri M, Colemont LJ, Phillips SF, Brown ML, Thomforde GM. Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies. Gastroenterology. 1990 Jul; 99(1):158-64.
    View PubMed
  578. Camilleri M. Disorders of gastrointestinal motility in neurologic diseases. Mayo Clin Proc. 1990 Jun; 65(6):825-46.
    View PubMed
  579. Proano M, Camilleri M, Phillips SF, Brown ML, Thomforde GM. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol. 1990 Jun; 258(6 Pt 1):G856-62.
    View PubMed
  580. Camilleri M, Fealey RD. Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal diseases: a causal association? Dig Dis Sci. 1990; 35:609-616.
    View PubMed
  581. Sodhi N, Camilleri M, Camoriano JK, Low PA, Fealey RD, Perry MC. Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci. 1989 Dec; 34(12):1937-42.
    View PubMed
  582. Camilleri M, Neri M. Motility disorders and stress. Dig Dis Sci. 1989 Nov; 34(11):1777-86.
    View PubMed
  583. Talley NJ, Camilleri M, Orkin BA, Kramlinger KG. Effect of cyclical unipolar depression on upper gastrointestinal motility and sleep. Gastroenterology. 1989 Sep; 97(3):775-7.
    View PubMed
  584. Fich A, Camilleri M, Phillips SF. Effect of age on human gastric and small bowel motility. J Clin Gastroenterol. 1989 Aug; 11(4):416-20.
    View PubMed
  585. Barbara L, Camilleri M, Corinaldesi R, Crean GP, Heading RC, Johnson AG, Malagelada JR, Stanghellini V, Wienbeck M. Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci. 1989 Aug; 34(8):1272-6.
    View PubMed
  586. Camilleri M, Colemont LJ, Phillips SF, Brown ML, Thomforde GM, Chapman N, Zinsmeister AR. Human gastric emptying and colonic filling of solids characterized by a new method. Am J Physiol. 1989 Aug; 257(2 Pt 1):G284-90.
    View PubMed
  587. Camilleri M, Proano M. Advances in the assessment of disease activity in inflammatory bowel disease. Mayo Clin Proc. 1989 Jul; 64(7):800-7.
    View PubMed
  588. Camilleri M, Phillips SF. Disorders of small intestinal motility. Gastroenterol Clin North Am. 1989 Jun; 18(2):405-24.
    View PubMed
  589. Camilleri M. Jejunal manometry in distal subacute mechanical obstruction: significance of prolonged simultaneous contractions. Gut. 1989 Apr; 30(4):468-75.
    View PubMed
  590. Camilleri M, Malagelada JR, Abell TL, Brown ML, Hench V, Zinsmeister AR. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology. 1989 Mar; 96(3):704-12.
    View PubMed
  591. Colemont LJ, Camilleri M. Chronic intestinal pseudo-obstruction: diagnosis and treatment. Mayo Clin Proc. 1989 Jan; 64(1):60-70.
    View PubMed
  592. Greydanus MP, Camilleri M. Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology. 1989 Jan; 96(1):110-5.
    View PubMed
  593. Camilleri M. Chronic intestinal pseudo-obstruction: new approaches in diagnosis and treatment. Investigation and Treatment of Upper Gastrointestinal Motility Disorders Proceedings of a symposium held in Ottawa, Canada Publishing Foundation, , pp 19-26 1988; Toronto:The Medicine.
  594. Abell TL, Malagelada JR, Lucas AR, Brown ML, Camilleri M, Go VL, Azpiroz F, Callaway CW, Kao PC, Zinsmeister AR, et al. Gastric electromechanical and neurohormonal function in anorexia nervosa. Gastroenterology. 1987 Nov; 93(5):958-65.
    View PubMed
  595. Shetty N, Camilleri M, Moss DW, Hodgson HJ. Subtle hyperthyroidism presenting as suspected hepatobiliary disease. J Clin Gastroenterol. 1987 Apr; 9(2):186-8.
    View PubMed
  596. Stanghellini V, Camilleri M, Malagelada JR. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut. 1987 Jan; 28(1):5-12.
    View PubMed
  597. Camilleri M. Clinical gastroenterology in Malta. Malta: Printex Publishers; 1987.
  598. Camilleri M. AIDS diagnosis and control: report on the current situation in Malta, March 1987. AIDS Diagnosis and Report of a WHO meeting held in Munich March 16-18, Koch MA, Deinhardt F, eds Munich MMV Medizin Verlag, 1988, pp 139-140 1987; Control:Current Situation.
  599. Vassallo M, Camilleri M. Monoclonal protein amyloidosis presenting with hepatomegaly Clinical Gastroenterology in Malta Camiller M ed Publishers Printex Malta, , pp77-81 1987.
  600. Camilleri M, Malagelada JR, Kao PC, Zinsmeister AR. Gastric and autonomic responses to stress in functional dyspepsia. Dig Dis Sci. 1986 Nov; 31:1169-1177.
    View PubMed
  601. Camilleri M, Brown ML, Malagelada JR. Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride. Gastroenterology. 1986 Sep; 91(3):619-26.
    View PubMed
  602. Camilleri M, Thompson DG, Malagelada JR. Functional dyspepsia. Symptoms and underlying mechanism. J Clin Gastroenterol. 1986 Aug; 8(4):424-9.
    View PubMed
  603. Camilleri M, Malagelada JR, Stanghellini V, Zinsmeister AR, Kao PC, Li CH. Dose-related effects of synthetic human beta-endorphin and naloxone on fed gastrointestinal motility. Am J Physiol. 1986 Jul; 251(1 Pt 1):G147-54.
    View PubMed
  604. Camilleri M, Brown ML, Malagelada JR. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology. 1986 Jul; 91(1):94-9.
    View PubMed
  605. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology. 1986 Jun; 90(6):1919-25.
    View PubMed
  606. Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJ, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology. 1986 May; 90(5 Pt 1):1121-8.
    View PubMed
  607. Camilleri M, Mearin F. Evaluation of gastric motility disorders by gastrointestinal manometry and radioscintigraphic gastric emptying studies. Gastrum. 1986 Apr; 34-40.
  608. Mearin F, Camilleri M. Diabetic gastroparesis. Gastrum. 1986 Apr; 40-5.
  609. Camilleri M. Alimentary tract and pancreas. New approaches to the diagnosis of functional upper gut disease. J Gastroenterol Hepatol. 1986; 1:273-279.
  610. Wood JR, Camilleri M, Low PA, Malagelada JR. Brainstem tumor presenting as an upper gut motility disorder. Gastroenterology. 1985 Dec; 89(6):1411-4.
    View PubMed
  611. Camilleri M, Malagelada JR, Brown ML, Becker G, Zinsmeister AR. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol. 1985 Nov; 249(5 Pt 1):G580-5.
    View PubMed
  612. Camilleri M, Malagelada JR, Stanghellini V, Fealey RD, Sheps SG. Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology. 1985 Jun; 88(6):1852-9.
    View PubMed
  613. Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest. 1984 Dec; 14(6):420-7.
    View PubMed
  614. Camilleri M, Malagelada JR, Kao PC, Zinsmeister AR. Effect of somatovisceral reflexes and selective dermatomal stimulation on postcibal antral pressure activity. Am J Physiol. 1984 Dec; 247(6 Pt 1):G703-8.
    View PubMed
  615. Malagelada JR, Camilleri M. Unexplained vomiting: a diagnostic challenge. Ann Intern Med. 1984 Aug; 101(2):211-8.
    View PubMed
  616. Camilleri M, Chadwick VS, Hodgson HJ. Vascular anomalies of the gastrointestinal tract. Hepatogastroenterology. 1984 Jun; 31(3):149-53.
    View PubMed
  617. Camilleri M, Victorino RM, Hodgson HJ. Halothane aggravation of chronic liver disease. Acta Med Port. 1984 Jun; 5(6):194-6.
    View PubMed
  618. Cox TM, O'Donnell MW, Camilleri M. Allelic heterogeneity in adult hereditary fructose intolerance. Detection of structural mutations in the aldolase B molecule. Mol Biol Med. 1983 Nov; 1(4):393-400.
    View PubMed
  619. Camilleri M, Krausz T, Lewis PD, Hodgson HJ, Pallis CA, Chadwick VS. Malignant histiocytosis and encephalomyeloradiculopathy complicating coeliac disease. Gut. 1983 May; 24(5):441-7.
    View PubMed
  620. Camilleri M, Pusey CD, Chadwick VS, Rees AJ. Gastrointestinal manifestations of systemic vasculitis. Q J Med. 1983 Spring; 52(206):141-9.
    View PubMed
  621. Cox TM, O'Donnell MW, Sochor M, Camilleri M, McLean P. Hereditary fructose intolerance: presence of a potent inhibitor of fructose-1-phosphate aldolase in the liver. Biochem Soc Trans. 1983; 11:202-203.
  622. Cox TM, O'Donnell MW, Camilleri M, Burghes A. Isolation and characterization of a mutant liver aldolase in adult hereditary fructose intolerance. J Clin Invest. 1983; 72:201-213.
    View PubMed
  623. Maton PN, Camilleri M, Griffin GE, Allison DJ, Hodgson HJF, Chadwick VS. Role of hepatic artery embolization in the carcinoid syndrome. Br Med J. 1983; 287:932-934.
  624. Camilleri M, Satti MB, Wood CB. Cystic lymphangioma of the colon. Endoscopic and histologic features. Diseases of the Colon & Rectum. 1982 Nov-Dec; 25(8):813-6.
    View PubMed
  625. Camilleri M, Hemingway AP, Chadwick VS, Blumgart LH, Hodgson HJ, Allison DJ. Embolization of an intrapancreatic aneurysm. Br J Radiol. 1982 Sep; 55(657):685-7.
    View PubMed
  626. Cox TM, Camilleri M, O'Donnell MW, Chadwick VS. Pseudodominant transmission of fructose intolerance in an adult and three offspring: Heterozygote detection by intestinal biopsy. N Engl J Med. 1982 Aug 26; 307(9):537-40.
    View PubMed
  627. Camilleri M, Murphy R, Chadwick VS. Pharmacological inhibition of chenodeoxycholic acid-induced secretion of fluid and mucus in the rabbit colon. Dig Dis Sci. 1982; 27:865-869.
    View PubMed
  628. Camilleri M, Schafler K, Chadwick VS, Hodgson HJ, Weinbren K. Periportal sinusoidal dilatation, inflammatory bowel disease, and the contraceptive pill. Gastroenterology. 1981 Apr; 80(4):810-5.
    View PubMed
  629. Chadwick VS, Camilleri M. Role of bile acids in the pathogenesis of diarrhea in various diseases. Acta Gastroenterol Belg. 1981; 44:43-48.
    View PubMed
  630. Camilleri M, Cooper BT, Adrian T, Bloom SR, Chadwick VS. Effects of vasoactive intestinal polypeptide and pancreatic polypeptide in the rabbit intestine. Gut. 1981; 22:14-18.
    View PubMed
  631. Camilleri M, Murphy R, Chadwick VS. Dose-related effects of chenodeoxycholic acid in the rabbit colon. Dig Dis Sci. 1980 Jun; 25(6):433-8.
    View PubMed
  632. Camilleri M, Fenech FF. Thrombophlebitis migrans in ulcerative colitis. Postgrad Med J. 1977; 52:762-763.
  633. Camilleri M. Anatomy of the newborn child. Chest-Piece (Malta) 1972 Dec.